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ABSTRACT
A-B family of toxins consists of plant toxins such as ricin and bacterial toxins such as cholera.
The A subunit is the enzymatic domain and the B subunit is the receptor binding domain.
Commonly, these toxins bind to the target cell plasma membrane receptors through their B
subunit followed by endocytosis and a transport to the endoplasmic reticulum (ER). Inside the
ER, the A subunit dissociates from the rest of the toxin, unfolds and triggers the ER quality
control mechanism of ER-associated degradation (ERAD). Most ERAD substrates are purged
out of the ER into the cytosol for proteasomal degradation. However, the low content of lysine
amino acid residues allows the toxin to evade polyubiquitination and subsequent proteasomal
degradation. The toxin A subunit refolds into an active conformation in the cytosol, setting off
downstream toxic events.
In the first part of my thesis, the hypothesis was tested that inhibiting the unfolding of the toxin
A subunit inside the ER will prevent ERAD activation, toxin export to the cytosol and
intoxication. The chemical chaperones glycerol and sodium 4-phenyl butyrate (PBA) were used
to inhibit the toxin A chain unfolding. In vitro biophysical experiments indicated that both
chemical chaperones indeed stabilize the cholera toxin A subunit and prevent cytotoxicity. In
case of ricin, both chaperones stabilized the toxin A chain but only glycerol prevented
cytotoxicity. Additional experiments showed that PBA-treated ricin A chain is destabilized when
exposed to anionic lipid membranes mimicking the properties of the ER membrane. In contrast,
anionic lipid did not prevent ricin A chain stabilization by glycerol. This explains why glycerol
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but not PBA blocked ricin intoxication, as only glycerol stabilizes ricin A chain in the presence
of ER membranes. Cholera toxin in contrast, remained either unaffected or slightly stabilized in
presence of anionic lipids both in presence and absence of PBA. This shows that destabilization
by anionic lipids is a toxin-specific rather than a general effect.
In the second part of my thesis, the effect of inner leaflet of plasma membrane on the structure of
cholera toxin A chain (CTA1) was studied. Since CTA1 refolds into an active conformation in
the cytosol in association with unidentified host factors, I hypothesized that inner leaflet of the
plasma membrane might play a role to stabilization and/or refolding of CTA1. CTA1 was shown
to be a membrane interacting protein, and membranes mimicking lipid rafts had a significant
stabilizing effect on its structure. Lipid rafts helped in the regaining of the tertiary and secondary
structure of CTA1, while non-raft lipids had a smaller stabilizing effect on CTA1 structure.
In the next part of my thesis, I studied the effect of membrane binding on the structure and
function of human pancreatic phospholipase A2 (PLA2). Lipid thermal phase transition was
found to have a dramatic effect on PLA2 activity. It was also established that although membrane
binding and insertion was essential for of PLA2 activity, lipid structural heterogeneity was more
important than the depth of membrane insertion for enzyme activation. Most importantly,
significant changes in PLA2 secondary and tertiary structures were identified that evidently
contribute to the interfacial activation of PLA2.
Overall, we conclude that the function of membrane binding enzymes can be significantly
modulated via conformational changes induced by interactions with membranes. Thus, we have
elucidated various roles of membrane lipids from unfolding and refolding to activation and
iv

modulation of membrane binding enzymes. Physical properties of lipids help in regulating
various aspects of protein structure and function and their analysis helped us in appreciating the
influence wielded by the membrane lipids in the enzyme’s surrounding environment.
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1.1

INTRODUCTION

Cellular Uptake of Bacterial & Plant Toxins

A-B toxins are composed of a catalytically active A subunit and a receptor binding B subunit
[120]. The two are usually joined by a single disulfide bond. Ricin and cholera toxin (CT) are
two typical AB toxins that nonetheless have distinct structures.
Ricin has a single B subunit, whereas CT has a homo pentameric B subunit [120]. Ricin toxin
(RT), like a typical A-B toxin, has a single disulfide bond joining the A subunit to the B subunit.
In contrast, the catalytic A1subunit of CT is bound by a single disulfide bond to the CTA2
subunit which rests inside the central pore of the B subunit. Despite these differences, both RT
and CT use similar mechanisms to reach the host cytosol. A-B toxins get inside the cell through
endocytosis [ ]. An important step for toxin uptake through endocytosis is adherence of the toxin
to cell surface receptors. The RT B subunit specifically binds to terminal galactose residues
which are present in many glycoproteins and glycolipids expressed at the cell surface [110,112].
CT, on the other hand, binds specifically to the GM1 ganglioside receptors expressed abundantly
in the intestinal epithelium [120]. After binding to their respective receptors, the toxins are
endocytosed. This can take place through multiple pathways. Clathrin-dependent endocytosis is a
well-characterized mechanism where endocytosis takes place through special coated pits that
form when the toxin binds to its receptor [113,114]. In caveolae-dependent endocytosis, the
cytosolic leaflet of the plasma membrane is coated with the 22 kD protein caveolin which binds
to cholesterol and facilitates formation of invaginated domains in the membrane [67,115-119].
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Because ricin can bind to a range of glycolipids and glycoproteins, it is endocytosed through all
of these pathways [121-123].
CT, in contrast, is endocytosed through lipid rafts and sometimes through caveolae [ ]. After
endocytosis, the toxin can be recycled back to the membrane, transported to the lysosomes for
degradation, or transported to the endoplasmic reticulum (ER). Only the last pathway is
productive for intoxication.
Transportation to the ER involves an intermediate step in which the toxin is first delivered to the
trans-Golgi. After reaching the trans-Golgi network, CT travels to the ER through A coatomer
protein I (COP-I) dependent pathway. Ricin transport from the trans-Golgi network to the ER is
Rab-6A dependent and COP -I independent. The CTA2 subunit has a KDEL tag at its Cterminal end, which acts as an ER retention signal. This keeps the toxin localized in the ER and
prevents its transport back to the Golgi apparatus other organelles of the endomembrane system
[64,68].
1.2

Endoplasmic Reticulum: Lipid and Protein Synthesis

The ER is subdivided into smooth and rough ER. Smooth ER is deprived of ribosomes and is the
center for lipid synthesis and transport to the other endomembrane organelles. The rough ER is
involved with protein synthesis and folding. In the rough ER, newly synthesized proteins enter
the ER through the Sec 61 translocon and are folded into their correct conformations with the
help of molecular chaperones. To prevent ER stress that could result from the production of
misfolded proteins, the ER has a quality control mechanism called ERAD [64, 68, 72, 80].
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1.3

ERAD: ER Quality Control

ER resident proteins, secretory proteins, membrane-bound proteins, and proteins residing in
organelles are all co-translationally inserted into the ER. These proteins undergo co- and posttranslational modifications. The modifications ensure proper folding of the proteins to their
native conformations. If the proteins cannot attain their proper conformations, then these
unfolded or misfolded proteins trigger the ER quality control mechanism of ERAD [ ]. This
causes the proteins to pass from the ER to the cytosol through Sec61 or Derlin-1 translocon
pores. Upon export into the cytosol, the proteins are ubiquitinated in preparation for proteasomal
degradation. The 19S cap of the 26S proteasomes identifies the polyubiquitin chain and targets it
for proteasomal degradation [71, 85,120].
1.4

Insight into the Mechanisms of Toxin Translocation

After binding to receptors on the cell surface, RT and CT move to the ER as an intact
holotoxins. Inside the ER, the disulfide bond linking the A subunit to the rest of the toxin is
reduced. The isolated A subunit unfolds and consequently activates the ERAD mechanism.
While ERAD substrates are degraded by the ubiquitin 26S proteasomal system,. A-B toxins
avoid this outcome due to an arginine-over-lysine amino acid bias in the A chain [68]. The
paucity of lysine residues prevents conjugation of ubiquitin molecules to the A chain; this is the
key step to being targeted to the 26S proteasome, so the toxin can avoid degradation in the
cytosol. Post- proteasomal escape, the translocated A chain refolds in the cytosol and modifies its
intracellular target to trigger the cellular effects of intoxication [127, 66,68].
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1.5

ER Translocating A-B Toxins

The A chains of A-B toxins which translocate from the ER to cytosol were initially presumed to
masquerade as misfolded protein to trigger the ERAD mechanism of translocation. However,
recent evidences suggests that the A chain assumes an unfolded conformation after dissociating
from the holotoxin inside the ER. In isolation, the A chain of both cholera toxin (CTA1) and
pertussis toxin (PTS1) are unstable and attain partially unfolded conformations at physiological
temperature (i.e., at 37°C). Ricin A chain is much more stable at physiological temperatures than
CTA1 and PTS1, yet it also unfolds at physiological temperature because of an interaction with
anionically charged lipids of the ER membrane [71,127]. This interaction has been shown to
destabilize the toxin structure.
The A chain of another ER translocating toxin, Shiga toxin A1 (STA1), interacts with anionic
charged lipids through its C-terminal domain [ ]. It has been hypothesized that lipid interaction in
the proximity of the translocons could destabilize STA1 making it ERAD substrate [ ]. The
interaction between CTA1 and anionic lipids has not been studied, and a potential destabilizing
effect on the toxin structure has not been tested yet [71, 72,125].
Previous work in our lab has shown that stalling A chain unfolding inside the lumen of the ER
could be a potential target for broad-spectrum anti-toxin therapeutics. If the dissociated A chain
is stabilized, then the ERAD system fails to recognize it as a substrate for translocation to the
cytosol. Since A chain export to the cytosol is stymied, it helps to contain the toxin in the ER
away from its cytosolic target. Our lab has already established the above principle with sodium
4-phenyl butyrate (PBA) which is a chemical chaperone and Food and Drug Administration
4

approved therapeutic for treating urea cycle disorders [ ]. Thermal unfolding of CTA1 was
restrained on treatment with PBA, which inhibited the ER-to-cytosol translocation of CTA1. CT
toxicity was blocked by PBA both in cultured cells and ileal loops. In this thesis work I tested the
potential ability of PBA to prevent the unfolding of ricin A chain and activity of ricin against
cultured cells. My experiments showed that, though PBA blocked the thermal denaturation of
ricin A chain, it failed to inhibit ricin intoxication. Further experiments using far-UV circular
dichroism (CD) demonstrated the destabilizing effect of POPG (an anionic lipid) on A subunit
structure was dominant over the stabilizing effect of PBA. In comparison, POPG did not have
any destabilizing effect on CTA1 and did not prevent the PBA-induced thermal stabilization of
CTA1. These results demonstrate that there are distinct events related to ERAD which actively
play role in exporting different ER-translocating A-B toxins to the cytosol. My work also
highlights the importance of toxin-phospholipid interactions for the translocation of ricin A
chain.

5

2

MATERIAL & METHODS
2.1

Surface Plasmon Resonance

When light passes through the media of higher refractive index to a lower refractive index, a part
of it is reflected and the rest refracted at the interface. If the one of the surfaces of the media is
gold plated, the incident monochromatic polarized light after reflection produces surface
plasmon resonance caused by the resonance energy transfer between surface plasmons and
evanescent wave. This resonance can be manipulated by adsorbing material over the thin gold
film. It has been shown that there is linear dependence between the mass concentration of
adsorbed molecules and the resonance recorded in refractive index units (RIU).
We used Reichert a (Depew, NY) SR7000 SPR Refractometer for our experiments. To create our
sensor plate, we activated a gold sensor plate with antibodies passed over following activation
with NHS / EDC for 10 min at the flow rate of 41 μl / min. We used this flow rate for all
procedures. To remove the activation buffer, we passed PBST (i.e. PBS containing 0.1% Triton
X-100 (pH 7.4)) over the plate for 5 min. To bind antibody to the activated sensor, anti-ricin A
chain antibodies (Vector Lab) suspended in 20 mM pH 5.7, sodium acetate (1:1000) were passed
over the plate for 10 min. We removed unbound antibody with a 5 min PBST wash and the
remaining active sites on the sensor plate were deactivated with 3 min exposure to 1 M, pH 8.5,
ethanolamine. Baseline measurement equivalent to the mass of antibody was made and then 20
μg/ml RTA in PBST was passed over the plate for 5 min. The increase in refractive index unit
(RIU) signal confirmed RTA binding to its antibody on the plate. This reading was then treated
as the new baseline and then 100 μM PBA was perfused over the plate containing bound toxins.
6

For the study of PBA interaction with ricin holotoxin, appended anti-ricin B chain antibodies
(Vector Lab) suspended in 20 mM pH 5.7, sodium acetate (1:500) to the activated slide and then
passed ricin holotoxin over the antibody coated slide at a (1:100) dilution in PBST. In vivo, ricin
holotoxin (Vector Lab) binds to the glycolipids /glycoproteins through its lectin binding B
domain. Similarly, on our plate the holotoxin was bound with its B subdomain to the antibodies
immobilized on the plate. Like in RTA, we perfused 100 μM of PBA suspended in PBST over
the holotoxin and detected signal for binding. For detecting the affinity of PBA for ricin B chain,
the experimental setup was exactly similar that of ricin holotoxin except ricin B chain was
perfused instead of ricin holotoxin over a slide with immobilized anti-ricin B chain antibodies.
2.2

Expression & Purification of hIB PLA2

E.coli BL21 (DE3) cells containing expression vector for hIBPLA2 expressed hIBPLA2 in
inclusion bodies. These inclusion bodies were sonicated and denatured using guanidium
hydrochloride and β-mercaptoethanol. Once denatured, these unfolded proteins were folded
using refolding buffer; 25 mM Tris, 5 mM L-cysteine, 5 mM CaCl2 and 0.9 M guanidium–HCl
at pH (8.0). This step was repeated 4 times prior to column purification. Since the pI of IB PLA2
is ~8, we chose to do cation exchanger chromatography using (HiTrap SP FF). The protein was
eluted using buffer made of refolding buffer containing 1.5 M KCl. Eluted fractions were again
dialyzed using 150 mM KCl and 25 mM Tris-HCl (pH 7.4). The samples were then loaded to
HiLoad 16/60 Superdex 75 size-exclusion column. The collected peak samples were dialyzed
against pure water and the protein concentration was determined by the absorbance at 280 nm
using UV-Vis spectroscopy (Varian). The activity was checked using PLA2 Activity Kit from
Cayman.
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2.3

CTA1- His Purification:

E.coli strain BL21 pLysS carrying CTA1-His6 expression plasmid for was grown at 37°C in
Luria-Bertani media and induced by adding 1 mM IPTG. After 4 hours induction, the cells were
pelleted and resuspended in lysis buffer containing 20 mM Tris (pH 7.5), 600 mM NaCl, 0.1%
Triton X-100, 1% deoxycholate, lysozyme, and a protease cocktail inhibitor. The pellets were
lysed using many freeze thaw cycles and then centrifuged at 13,000 rpm for 30 min. The
supernatant was mixed with 2 ml Talon resin (Clonetech) and, after 2 hours of mixing; the beads
were pelleted at 800 X g and then resuspended in 20 mM Tris (pH 7.0), 8 M urea, and 600 mM
NaCl for binding and placed onto a gravity column (Clonetech). The beads were then treated
with increasing concentrations of 2 ml of imidazole (10-100 mM) and eluted in 0.5 ml fractions.
For refolding, the dialysis was done immediately prior to every experiment using 6 buffer
changes of 500 ml sodium borate buffer (pH 7.0) The dialysis step was started with 6 M urea
exchange at 4°C and pH 7.0. The next exchanges were at 4, 2, 1 and 0 M urea for 2 hours each.
One more exchange in urea free buffer was done for 2 hours to make sure that all the urea had
been dialyzed out. For dialysis, we used Slide-a-lyzer 3500 MWCO from, Pierce, Rockford, IL.
2.4

Liposome Preparation

Lipid solutions of 10 mM POPC were made in chloroform and 10 mM POPG in chloroform:
methanol (2:1, v/v). The lipids POPC and POPG were mixed in the ratio of 80% and 20%
respectively and then the solvent was evaporated under a steady stream of nitrogen. Later, it was
vacuum dried for 4 hours in a desiccator. The dried mixture of lipids was resuspended in 10mM
Na/K phosphate buffer, 50 mM NaCl at pH 7.2 to prepare large unilamellar vesicles (LUV). The
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mixture was vortexed thoroughly and then it was extruded through 100 nm pore size
polycarbonate membranes using a Lipofast extruder (Avestin, Ottawa, Canada) with 30 passes.
All the extrusion was done at room temperature. After extrusion the vesicles were stored at 4°C
for future experiments.
2.5

Model Inner leaflet of Plasma membrane

In order to simulate the intestinal inner leaflet of the plasma membrane, we mixed lipids
according to their percentages mentioned in Table I such that the total lipid concentration
amounted to 8 mM. Since the lipids were dissolved in chloroform, after mixing they were first
dried slowly under the slow stream of nitrogen gas. Once it all evaporated, it was vacuum dried
for another 4 hours. The lipids were then resuspended in 10 mM Borate buffer containing 100
mM NaCl at pH 7.0 and, after thoroughly mixing, were 30 times passed through the extruder.
The large unilamellar vesicles (LUV) were collected and stored at 4°C for a week.
2.6

Model Lipid Rafts

Simulation of the intestinal inner leaflet of lipid rafts on the plasma membrane was done in a
similar process as mentioned above, starting with the mixing of lipids according to their
percentages mentioned in chapter 4 such that the total lipid concentration amounted to 8 mM.
This was followed by drying, resuspending, extruding, and storing at 4°C as mentioned above.
The final concentration of lipid and toxin were kept the same to maintain consistency for all
experiments.
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2.7

Liposome Preparation for PLA2 Experiments

For vesicle preparation, lipid solutions in chloroform or a chloroform-methanol (2:1, v/v)
mixture were combined at the desired proportions. The solvent was evaporated under nitrogen
and then by incubation under vacuum overnight. To prepare LUVs, an aqueous buffer was added
to the dry lipid, followed by vigorous vortexing and then extrusion through 100 nm pore-size
polycarbonate membranes using a Lipofast extruder. Vortexing and extrusion were done at room
temperature for vesicles composed of POPC, POPG, DMPC, DMPG, and their mixtures. For
lipids with higher Tm, it was necessary to heat the suspension above Tm, e.g., to 50°C for DPPC
and DPPG and to 60°C for DSPC and DSPG. In the latter cases, extrusion was performed with
the extruder immersed in water heated to the desired temperature in a large beaker. Following
extrusion, the lipid suspensions were allowed to equilibrate at room temperature for 1 hr prior to
the measurements.
2.8

CD Measurements: Plasma Membrane & Lipid Rafts

CD measurements were done in 4 mm path length cuvettes using a Jasco 810
spectrofluoropolarimeter. The Far-and Near-UV CD and the fluorescence measurements were
done simultaneously after adding lipid to 14.8 µM of His-tagged CTA1 such that the final
volumes were 220 µl. The final lipid concentration was 800 µM in the mixture. The lipids were
put in excess to ensure that lipids from all the sides surround each toxin molecule. The
temperature was ramped in 2°C from 20 to 34°C; 1°C from 34°C to 40°C and again 2°C
increments from 40°C to 60°C. At each temperature, the sample was incubated for 4 min prior to
taking measurements. Temperature regulation was done using a Jasco PFD-425S Peltier
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temperature controller. All CD spectra obtained (θobs) were converted to mean molar ellipticity,
[θ], by using the following formula: θobs/cnl where, n stands for number of amino acid residues,
c for molar concentration of sample and l stands of path length of cuvette.
2.9

CD Measurements: CTA1 Refolding Assay

These CD measurements were also done in exactly the same preparation as mentioned above.
The initial measurement was done at 18°C with toxin alone, and then the temperature was
brought up to 37°C. After adding plasma membrane or lipid rafts, I incubated the toxin-lipid
mixture for 5 min and then took the reading. After that, the sample was incubated for another 30
min prior to taking a final reading. In the previous experiments the lipids were added to the
folded conformation and we have seen that it prevents unfolding of CTA1. In these experiments
we tested whether the lipids refold or stabilize the unfolded CTA1.
2.10 Membrane Insertion of PLA2
Insertion of the N-terminal helix of hIBPLA2 was determined by differential quenching of
fluorescence of Trp3 by brominated lipids or the Br2PCs which were brominated at 6,7; 9,10 and
11,12 positions of the sn-2 acyl chain. Phase transition studies of the DMPC:DMPG (70:30)
model membrane showed that the Tm of the vesicle was 24°C. Previous studies have used 20
mol% of brominated lipids to determine membrane depth. In our experiments, we studied the
effect of the 20 mol% brominated lipids on the Tm of the DMPC:DMPG model membranes. 20
mol% Br2PC were substituted in place of DMPC lipid. Since 20% Br2PC shifted the vesicle to a
higher melting temperature, we decided to go ahead with the 10 mol% of Br2PC. The Tm was
found to be consistent with that of pure vesicle. First, we took spectra of Trp fluorescence of
11

hIBPLA2 using vesicles with no brominated lipids (i.e. composed of 70 mol% DMPC and 30
mol% DMPG). The concentration of lipid vesicles was 0.8 mM in the solution composed of 50
mM HEPES, 1 mM EGTA and 50 mM NaCl (pH 7.4). The PLA2 concentration was 6 µM. The
lipid and enzyme concentrations were constant for all sets of experiment. All spectra with
brominated lipids were corrected using the spectra of bare lipids (i.e. without Br2PC) as reference
spectra which were already corrected by subtracting the spectra without PLA2. The
concentrations of lipid and enzyme were decided based upon the dissociation constant which was
2 μM for hIBPLA2 (calculated by Qin et al for 30 mol% anionic lipids). At 0.8 mM of lipid
concentration in presence of 6 µM protein, almost 80% of PLA2 is bound with the membrane.
The data was interpreted using “distribution analysis” [31,32]:

Here, the F0 corresponds to fluorescence intensity without quencher and F is fluorescence
intensity in presence of quencher. S indicates the area encompassed by the distribution curve and
this is directly proportional to the amount of exposure of the tryptophan fluorophore to the
membrane hydrophobic core. σ indicates the dispersion of the distribution curve, and it depends
not only on the structural disorder and heterogeneity of the experimental system but also on the
varying sizes of the fluorophore and quencher. Distance from the membrane center is denoted
by h, and hm denotes the most probable location of the fluorophore from the membrane center.
The bromines in the lipids are located at 11, 8.3 and 6.5 Å from the membrane center for 6,7-,
9,10-, and 11,12- Br2PCs respectively. The three values of ln (F0/F) were obtained for the 3
different brominated lipids and were plotted as a function of distance from the membrane center
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and after their fitting we got the values for the area under the curve (S), distribution of the curve
(σ) and the most probable distance of the fluorophore from the membrane center (hm) [53]. All
the samples were incubated for 5 min at each temperature before recording each spectrum. All
experiments were done in 4 x 4 mm2 quartz cuvette with constant stirring by a magnetic stirrer.
2.11 Thermal Protein Unfolding
We did thermal unfolding profiles for ricin and CT using CD, and then we calculated mean
molar ellipticities for UV at far-UV CD [θ208] and [θ220] and near-UV CD at [θ280]. These values
were plotted as functions of temperature. Temperature-dependent unfolding analysis was done
using equation [99]
X = f LX L + (1-f L) X H
Here, X is measured ellipticity at particular temperature and fL symbolizes amino acid residues
that correspond to low temperature native conformation fL is represented by
f L= exp (-ΔG/RT)/[1+exp(-ΔG/RT)]
X L and X H denote values low and high temperatures
Temperature-dependent free energy of unfolding (ΔG) is illustrated by
ΔG = ΔH (1-T / Tm) + ΔC [T- Tm – T ln (T / Tm)]
ΔH stands for enthalpy change during protein unfolding, T for absolute temperature, ΔC for
change in heat capacity during unfolding, and Tm transition temperature of protein from folded to
an unfolded state.
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2.12 Protein-Lipid Interaction Using Fluorescence Spectroscopy
To detect binding of CTA1 to non-raft membranes and, raft lipids, we added fluorophore pyrene
labeled head group phosphatidylethanolamine (PE) to the vesicles.
Δ F = Δ Fmax [L]/ [L]1/2 + [L]
KD = [Pf] [δLf]/ [Lb] where, [Pf] corresponds to total free protein and [Lb] bound lipids to protein
Hence, [Lb]= N [Pb] ; [Pf]= [P]- [Pb] and δ[Lf]= δ[L]- N [Pb]
The basic assumption of this model is that a change in protein fluorescence intensity is
proportional to lipid bound to the protein, i.e. KD = ([P]- ΔFrel [P]) (δ[ L]- ΔFrel N[P]) / ΔFrel N[P]
ΔFrel can be solved as:

KD = δ / N [L]1/2 – [P] / 2
At half saturation of protein bound to lipid membranes, [L] = [L]1/2, ΔFrel = 0.5, and ½ [P]= [Pb]
A fraction of total lipid available for interaction δ and the protein binds to N number of lipid
molecules. The saturating value of Δ F at high lipid concentrations is denoted by Δ Fmax and the
lipid concentrations corresponding to half the binding saturation, [L]1/2 during which Δ F = 1/2 Δ
Fmax Binding data was calculated using:
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To calculate KD, we constructed theoretical curves till we got the best fit for the experimental
isotherm. This method is accurate and stringent as this method allows only one unique value of
N and KD fit the experimental results.
2.13 Fluorescence Spectroscopy
Aromatic amino acids such as phenylalanine, tryptophan, and tyrosine have the ability to absorb
light of shorter wavelength and then emit or fluoresce at longer wavelength. Of the three,
tryptophan fluorescence is most commonly studied. The indole chromophore of tryptophan is
very sensitive to the surrounding environment, which makes it the ideal choice to study protein
conformational changes and interaction with other molecules. Unfolding of the protein is
accompanied by the exposure of hydrophobic residues such as Trp to water. For all thermal
unfolding studies of proteins using fluorescence spectroscopy, the excitation was done at 290 nm
and the shift in λmax of the emission spectra was plotted as a function of temperature. A red shift
would indicate unfolding of protein, whereas a blue shift would indicate refolding of the protein.
2.14 Lipid Phase Transition Studies
Laurdan (6-dodecanoyl -2-dimethylaminonaphthalene) is a fluorophore which has been used to
study the phase state of phospholipid membranes. The fluorophore has a lauric acid tail which
helps it anchor at the phospholipid acyl chain. Since it localizes at the interface of the lipid
bilayer which has a mix of both hydrophilic and hydrophobic environments, it shows a red
spectral shift during the phase shift from liquid ordered (lo) to liquid disordered state (ld). We
used this fluorophore to study the temperature-dependent lipid phase transition using generalized
polarization (GP) of laurdan. The effect on the melting temperature (Tm) of zwitterionic lipid
15

vesicles was studied in the presence and absence of anionic lipids and also in presence of lipid
fluorophores.
During phase transition from liquid ordered (lo) to liquid disordered state (ld), or in other words
from gel to fluid state at T≥ Tm, laurdan undergoes dipolar relaxation in the presence of water
molecules which enter the interface during the lipid phase transformation. For these experiments,
laurdan was excited at 360 nm and emission spectra were collected between 380 and 560 nm. At
temperatures below Tm, the lipids in the vesicle are in liquid ordered (lo) or the gel state (i.e. they
are tightly packed with minimum amount of water at the interface causing non relaxed emission
peak at 440 nm). As the temperature crosses Tm, the fluidity of the membrane increases, and the
movement of water molecules at the interface increases which leads to prominent solvent-relaxed
peak at 475 nm. GP of laurdan was calculated as GP = (I440 - I475) / (I440 + I475), where I stands
for fluorescence intensities at their respective wavelengths. The midpoint of sigmoidal decrease
of GP gives the value of Tm of the lipid vesicle.
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3

RICIN: LIPIDS AND MECHANISM OF TOXIN TRANSLOCATION
3.1

Introduction

Many plants express proteins which have toxic properties. One type is a ribosomal inactivating
protein (RIP) an N-glycosidase that depurinates the 28S rRNA in the larger subunit of ribosome.
Ricin is a type II RIP that depurinates ribosomes at the α-sarcin loop which is highly conserved
from prokaryotes to humans. In this loop there is a GAGA sequence, and the toxin cleaves the
first adenine through an enzymatic reaction causing an irreversible damage to the 28S rRNA
structure which disrupts the binding of elongation factors (EF) 1 and 2 to the assembled
ribosomal subunit. This interrupts the translational machinery, halting the protein translation and
eventually leading to cell death [127,128,129].
Ricin is derived from the plant Ricinus communis and, like CT belongs to the family of A-B
type toxins. In A-B type toxins, the A subunit is the catalytic enzyme unit and the B subunit is
the cell binding unit. A subset of A-B toxins enters the eukaryotic cytosol after following a
retrograde vesicular transport pathway from the cell surface to the ER. CT, Pertussis toxin (PT),
Shiga toxin (ST), and the plant toxin ricin belong to the ER translocating family of A-B toxins.
Unlike CT and ST that have homopentameric receptor binding B subunits, ricin has a single B
subunit. This 32 kD B chain lectin is known to bind a wide range of glycoconjugates with
terminal galactose residues, so there is no single cellular receptor for ricin toxin B subunit (RTB)
[127,128,129].

17

3.2

Intracellular Trafficking of Ricin

Surface bound ricin travels through the cell in a similar fashion as CT. Some of the internalized
ricin moves to the lysosomes where it is degraded, some is recycled back to the surface, and
some reaches the ER through retrograde transport. After it reaches the ER, the catalytic A chain
dissociates from the rest of the toxin and unfolds. The unfolded A chain is treated as an ERAD
substrate and purged out of the ER. Once in the cytosol, most of the protein molecules evade the
proteasomal degradation, refold, and become cytotoxic by inhibiting protein translation. For
decades people have unsuccessfully tried to design inhibitors against the folded conformation of
ricin A chain (RTA). Hence, we thought of looking at an alternative therapeutic solution, where
we wanted to prevent RTA unfolding inside the ER to thereby prevent its translocation into the
cytosol. The chemical compounds that we used fall under a special category of compounds
known as chemical chaperones [136-137].
3.3

Chemical Chaperones & Sodium 4 Phenyl Butyrate (PBA)

Low molecular weight compounds that help correct the protein conformation and prevent
aggregation are known as chemical chaperones. They work non-selectively to stabilize protein
structures by their action which mimics the function of molecular chaperones. Chemical
chaperones can belong two major categories: osmolytes and hydrophobic compounds. Osmolytes
such as di-methyl sulfoxide (DMSO) and glycerol prevent protein aggregation and allow
misfolded proteins the opportunity to gain a proper conformation. The problem with osmolytes is
that they have low therapeutic value. The hydrophobic compounds such as PBA have shown a
lot of promise. PBA is an FDA-approved drug and has been used to treat urea cycle disorders in
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children. PBA prevented misfolding and aggregation , cystic fibrosis, beta thalassemia, etc. and
has shown high therapeutic value. Our lab, for the first time, used PBA against an A-B toxin in
which unfolding is a critical step for intoxication. We have shown that PBA holds lot of promise
in containing the cholera intoxication, so we now wanted to test whether PBA can contain ricin
intoxication [131-135].
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3.4

Results

Recent experiments with CTA1 have shown that PBA can block ER-to-cytosol export by
preventing the thermal unfolding of CTA1. This contains CT intoxication. Unfolding of the A
chain is also an essential step for RTA recognition as an ERAD substrate and RTA translocation
to the cytosol from the ER. Hence, we hypothesized that PBA would prevent the unfolding of
RTA, arrest the exodus of ricin A chain into the cytosol from the ER, and thus inhibit ricin
intoxication.
3.4.1

PBA Binds to Ricin Holotoxin

We coated an SPR plate with anti-RTB antibodies and then bound the ricin holotoxin to the
antibody-coated plate. The change in signal that occurred upon holotoxin binding to the sensor
coated with the anti-RTB antibody was taken as our baseline signal, and then we perfused PBA
over the holotoxin-coated slide. We saw that PBA binds to the ricin holotoxin as indicated by
the increased RIU signal (Fig. 3-1).
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Figure 3-1 Binding of PBA to Ricin Holotoxin
SPR signal of PBA (100 µM) perfused over an SPR sensor coated with the ricin holotoxin. The
temperature was kept constant at 37°C. The arrow denotes the time PBA was removed from the
perfusion buffer.

21

3.4.2

Binding of PBA to Ricin A & B Chain

As previous experiments with ricin holotoxin showed binding with PBA, we wanted to see
whether PBA could bind to both the RTA and RTB subunits. First, RTA was appended to a
sensor slide using anti-ricin A chain antibodies. These antibodies were immobilized on the gold
sensor slide using NHS and EDC. We treated the signal of RTA appended to the antibodies as
our baseline signal. We then perfused PBA over the slide and observed the rise in signal,
signifying direct PBA binding to RTA (Fig 3-2 A). This binding or interaction was detected as
an increase in the refractive index unit (RIU) of the sensor slide.
To test whether PBA binds to RTB, we coated the SPR plate with anti-ricin B antibodies and
bound the RTB to it. The change in signal upon RTB binding to the plate was taken as our
baseline signal, and then we perfused PBA over the plate. As shown in Fig. 3-2 B, we saw that
PBA did not bind to RTB. So, we conclude that PBA binds with RTA and must likely the RTA
component of the ricin holotoxin.
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A

B

Figure 3-2 Binding of PBA to Ricin A or B Chain
SPR signal of PBA (100 µM) perfused over SPR slides coated with ricin A chain (A) or ricin B
chain (B). The temperature was kept constant at 37°C. The arrow denotes the time PBA was
removed from the perfusion buffer.
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3.4.3

Thermal Stability of Ricin A Chain With/Without PBA

We wanted to test whether PBA stabilized the structure of RTA. To test the effect of PBA on
RTA, we used far-UV CD to study its thermal denaturation in the presence and absence of PBA.
We dialyzed 1.6 µM recombinant RTA in phosphate buffer (10 mM, pH 7.2) for 4 hours with 2
exchanges. From the crystal structure of RTA it is clear that RTA has a predominant α helical
structure. RTA displayed strong minimum around 210 nm, indicative of α-helix structure that
decreased in intensity with the rising temperature from 20 to 60°C. Thermal unfolding of ricin
secondary structure is shown by the change in color from blue to red which corresponds to the
change in temperature from 20°C to 60°C. The temperature-induced loss of RTA secondary
structure of RTA was characterized with a Tm of 44°C (Table 3-1). This value was consistent
with previous reports on the structural stability of RTA. RTA when treated with 100 µM of PBA
also showed a single minimum around 210 nm, and its thermal unfolding was characterized with
a Tm of 48°C. Comparing the melting temperature of PBA-treated and untreated ricin A chain
showed that, on treatment of PBA, there is secondary structure stabilization of ricin A chain by
5-7°C.
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Figure 3-3 Thermal Stability of RTA With/Without PBA
Far-UV CD spectra of RTA only (1.6 µM in 10 mM Na/K phosphate buffer, 50 mM NaCl at pH
7.2) measured in a 0.1 mm path length cuvette. The temperature was increased stepwise from
20°C-60°C , indicated by the changing color from blue to red. B) The far-UV CD RTA in
presence of 100 µM PBA during a stepwise increase in temperature from 20-60°C is indicated
with the change in color from blue to red. C) Tm is calculated by plotting mean molar ellipticity
[θ]208 as a function of temperature for ricin alone (red circles) and ricin in presence of PBA (blue
circles). The black line in both the cases indicates the simulated curve.
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Table 3-1 Summary of RTA Experiments with PBA, ER Mimicking Membranes and
Glycerol

RTA

PBA

POPC:POPG

GLYCEROL

(8:2)

Tm (°C )
±

range

of

independent expt.

+

+

44.2 ± 0.7

+

+

+

+

48.5 ± 0.5

+

27.4 ± 1.0

+

33.4 ± 0.5

+

+

+

+

49.3 ± 0.8

+

43.5 ± 1.0
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2

3.4.4

Thermal Stability of Ricin A Chain with ER Mimicking Membrane

Cell culture experiments have shown that PBA does not inhibit RTA intoxication unlike CTA1 [
Mansfield Burlingame & K Teter].

Isolated CTA1 by itself is unstable at physiological

temperatures whereas RTA is stable. Previous studies have shown that an interaction with
negatively charged phospholipids such as phosphatidylglycerol (PG) and phosphatidylserine
(PS) causes destabilization of RTA at 20°C, whereas, neutral or zwitterionic lipids had little or
no effect on the RTA structure [73,130]. However, the Tm of ricin secondary structure was not
determined in these studies. ER contains anionic phospholipids which could place RTA in
unfolded conformation. We hypothesize that the destabilization by anionic phospholipids is
dominant over PBA induced stabilization of RTA structure. To test this hypothesis we first
confirmed the destabilizing effect of anionic lipids on RTA structure (Fig. 3-4). The lipid
vesicles were 80% POPC (zwitterionic lipid) and 20% POPG (anionic lipid). The lipid was put
in excess (600 µM) to ensure all the protein molecules (2 µM) were surrounded by lipid
molecules. Treatment with anionic lipids reduced the Tm for RTA secondary structure from 44.2
to 27.4°C in presence of lipids (Table 3-1). Anionic lipids thus had a strong destabilizing effect
on RTA lowering its secondary structure Tm by 17°C.
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A

B

Figure 3-4 Thermal Stability of Ricin A Chain with ER Mimicking Lipids
A) Far UV CD spectra of ricin A chain and 600 µM ER mimicking lipids POPC:POPG (8:2) in
(2.1 µM in 10 mM Na/K phosphate buffer, 50 mM NaCl at pH 7.2 ) measured in 0.1 mm path
length cuvette. The temperature was increased stepwise from 20°C-60°C indicated by changing
the color from blue to red in panel. B), the red dots denote the thermal unfolding profile of ricin
A chain by itself and blue color indicates the unfolding profile of ricin A chain in presence of ER
mimicking lipids.
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3.4.5

Thermal Stability of Ricin A Chain in the presence of both PBA and ER
Mimicking Membranes

The destabilizing effects of POPG were also seen when RTA was pre-incubated for 30 min. in
presence of PBA prior to adding lipids (Fig. 3-5). The thermal unfolding profile was similar to
the RTA profile with lipids alone. Ricin A chain exhibited secondary structure Tm of 31°C on
treatment first with PBA and then with POPG, which was slightly more stable when compared to
the 27°C Tm calculated for POPG-treated ricin A chain (Table 3-1). These results indicated that
the ricin A chain secondary structure is stabilized by PBA but destabilized by the anionic POPG
lipid. It also showed that the lipid-induced destabilization of secondary structure is dominant
over the stabilizing effects of PBA. This explains why PBA treated cells failed to inhibit ricin
intoxication. PBA bound stabilized RTA became destabilized on interaction with anionic ER
phospholipids.
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A

B

Figure 3-5 Thermal Stability of RTA Incubated with PBA and ER- Mimicking Lipids
A) Far-UV CD spectra of RTA pre-incubated with PBA prior to adding 600 µM ER- mimicking
lipids POPC:POPG (8:2 . The temperature was increased stepwise from 20°C-60°C as indicated
by the changing color from blue to red. B) Red dots denote the thermal unfolding profile of
RTA by itself; blue color indicates the unfolding profile of RTA in presence of ER-mimicking
lipids, and green dots indicate the thermal unfolding profile RTA incubated with both PBA and
ER mimicking lipids.
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3.4.6

PBA Bound to Ricin A Chain is Displaced by ER-Mimicking Lipid
Membranes

Our CD data showed that PBA-treated RTA was destabilized by anionic phospholipids. So, to
understand the mechanism of this destabilization, we appended ricin A chain to an SPR slide as
mentioned previously. Then we perfused PBA over the slide. When the signal resulting from
PBA binding to RTA stabilized (i.e. reached equilibrium), we perfused POPC: POPG (8:2) lipid
vesicles over the plate in the continued presence of PBA. We saw that the PBA bound to the
toxin was displaced in the presence of POPC:POPG vesicles (Fig. 3-6A). In the control
experiment we added the lipid vesicles alone and observed that they gave no signal as indicated
by a straight line in the Fig 3-6 A. This suggested the lipid vesicles induced a structural change
in ricin A chain which weakened its interaction with PBA and caused PBA to be released as
denoted by the fall in signal. As an additional control we replaced the PBA buffer with another
buffer containing PBA and saw no drop in signal from the RTA sensor, indicating that PBA
remained bound to the toxin (Fig 3-6 B).
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A

B

Figure 3-6 Effect of Anionic Lipids on PBA Bound RTA
SPR signal of PBA (100 µM) perfused over a sensor coated with RTA. The temperature was
kept constant at 37°C. A) After 250 sec, the lipids were added to ricin A chain in continued
presence of PBA and we saw that PBA got released from ricin A chain as denoted by the fall in
signal. (B) At 250 sec, buffer with PBA was replaced with outer PBA buffer PBA remained
bound to ricin A chain after buffer exchange.
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3.4.7

PBA Does Not Bind to Unfolded Ricin A Chain

My previous experiment showed that PBA molecules bound to RTA are released from the toxin
in the presence of anionic lipids. Earlier, thermal unfolding profile showed that PB-treated RTA
was destabilized by anionic lipids, with nearly half of the secondary structure lost at
physiological temperature. This could be due to competitive inhibition or to a lipid-induced
structural change in RTA. In the latter case, PBA would not be able to bind to unfolded RTA.
Till now we had added PBA to folded RTA. To test the affinity of PBA for unfolded RTA, we
heated ricin A chain to 50°C for 30 min and then added the denatured toxin to an SPR plate
containing immobilized anti-RTA antibodies. Then, we perfused PBA over the plate and saw
that there was little or no binding of PBA to unfolded RTA (Fig. 3-7). This explains when
interaction of RTA with anionic lipids destabilizes the secondary structure which displaces PBA.
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Figure 3-7 Binding of PBA to unfolded RTA
SPR signal of PBA (100 µM) perfused over an SPR sensor coated with denatured RTA.
Readings were taken at 37°C.
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3.4.8

Thermal Unfolding Profile of Ricin A Chain in Presence of Glycerol and/or
ER Mimicking Lipid Membranes

Cell culture experiments conducted in our lab by Dr. Shane Massey have shown that, unlike
PBA, 10% glycerol was able to protect Vero cells from ricin. Our hypothesis was RTA preincubated with glycerol would not be destabilized in presence of anionic lipids, and, hence
would not become an ERAD substrate This provides a molecular explanation for why glycerol
and not PBA has protective effect on ricin treated cells. . To see whether glycerol stabilized
RTA, thermal unfolding profile was calculated from the far-UV CD spectra recorded for glycerol
treated RTA (Fig. 3-8 A,C). Glycerol shifted the RTA secondary structure Tm upward by 5°C to
49°C (Table 3-1). The shift was comparable with that of PBA.
To test whether RTA incubated with glycerol could overcome the destabilizing effect of anionic
phospholipids, we incubated RTA with 10% glycerol for 30 min and then we added POPC and
POPG (80%:20%) vesicles. We saw that the presence of anionic lipids did not destabilize
glycerol treated RTA as it did in presence of PBA (Fig 3-8 B,C). Glycerol and ER mimicking
lipid membranes shifted the RTA secondary structure Tm by 1°C to 43°C (Table 3-1). The Tm
was comparable to that of RTA by itself. This explains why treatment of 10% glycerol and ricin
holotoxin did not show cytotoxicity. Glycerol stabilized RTA and glycerol treated RTA did not
get destabilized in presence of anionic phospholipids. This also indicated that chemical
chaperones such as PBA and 10% glycerol have completely different mechanisms for stabilizing
RTA secondary structure.

A

B

C

Figure 3-8 Thermal Stability of RTA with Glycerol and ER-Mimicking Lipids
A) Far-UV CD spectra of RTA (2.1µM ) pre-incubated with glycerol. B) Far-UV CD spectra of
RTA (2.1µM ) pre-incubated with glycerol for 30 min. prior to adding 600 µM ER mimicking
lipids POPC:POPG (8:2). For both A and B, the temperature was increased stepwise from 20°C60°C as indicated by the changing color from blue to red. C) The red dots denote the thermal
unfolding profile of RTA by itself; blue dots indicate the unfolding profile of RTA in the
presence of ER-mimicking lipids; and green dots indicate the thermal unfolding profile of RTA
pre-incubated with glycerol prior to treatment with ER mimicking lipids.
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3.4.9

Thermal Stability of CTA1 Chain With/Without ER- Mimicking Lipid
Membranes and PBA

Previously, it has been shown that the thermal unfolding of CTA1 was inhibited by PBA.
This blocked CTA1 export from the ER to the cytosol and eventually CT-induced intoxication as
well. So, in the next set of experiments we wanted to test whether POPG (anionic lipid) in
general is a protein destabilizer. Since, PBA rescued CT treated cells from intoxication, we
hypothesized that anionic ER mimicking membrane do not affect the PBA-stabilized CT
structure. CD (near and far UV) and fluorescence spectroscopy were used to study the thermal
unfolding of CTA1 (Fig. 3-9). Measurements were performed with CTA1 alone (Fig. 3-9
A,B,C), CTA1 and POPC:POPG (8:2) lipid vesicles (Fig. 3-9 D,E,F) and CTA1 pre-incubated
for 30 min with PBA and then treated with ER mimicking phospholipid membranes (Fig. 3-9
G,H,I). Thermal unfolding profiles for each condition are shown in (Fig. 3-9 J,K,L).
The results show that the presence of anionic lipids slightly stabilized the secondary structure of
CTA1 as the Tm was shifted upwards by 3°C to 37°C. PBA stabilized CTA1 was not destabilized
by the ER-mimicking membranes and the Tm was at 42°C (Table 3-2). Similarly, anionic lipids
did not destabilize the tertiary structure of CTA1 and the Tm was shifted from 31 to 33°C. The
PBA stabilized tertiary structure of CTA1 remained stabilized in the presence of mimic
phospholipids with Tm at 36°C (Table 3-2). Fluorescence spectroscopy studies also coincided
with the CD data and showed the shift in Tm from 34°C to 36°C in presence of anionic lipids
(Table 3-2). On treatment with ER mimicking membranes, PBA stabilized CTA1 remained
stabilized with its Tm at 39°C (Table 3-2).
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Thermal unfolding profiles for far-UV CD were made by plotting the mean molar ellipticity [θ]
at 220 nm as a function of temperature. For near-UV CD, the unfolding profiles were made by
[θ] at 280 nm as a function of temperature. For fluorescence, the wavelength at maximum
intensity (λmax) was plotted as a function of temperature.
The results indicate neither the neutral (POPC) nor the anionic lipids (POPG) destabilized the
CTA1 secondary and tertiary structure. Rather, both the secondary and tertiary structures of
CTA1 were slightly stabilized in presence of lipid vesicles. The data further show that lipid
vesicles did not reverse the stabilizing effect of PBA on CTA1 structure. The destabilizing effect
of anionic lipids on RTA is not a general property that affects all A-B toxins. CTA1 was
stabilized by PBA even in the presence of lipids, which explains why PBA had a protective
effect on CT-treated cells but not ricin-treated cells. Although the results show slight upward
shift in Tm of CTA1 in the presence of ER mimicking membranes, but this stabilization is not
enough to prevent unfolding of CTA1 inside the ER at physiological temperature and pH. Thus,
ER membrane lipids do not prevent CTA1 unfolding at physiological temperatures nor do they
facilitate the unfolding of CTA1.
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Figure 3-9 Thermal Stability of CTA1 in the Presence of ER Mimicking Lipids and PBA
The thermal unfolding of CTA1 only (A-C), CTA1 treated with ER-mimicking lipids (D-F) and
CTA1treated with both PBA and ER-mimicking lipids (G-I). The temperature dependent change
in structure was monitored by far-UV CD (A,D,G), near-UV CD (B,E,H) and fluorescence
spectroscopy (G,H,I). The temperature was increased stepwise from 20°C-60°C as indicated by
the change in color from blue to red. In panels (J-L) the unfolding of CTA1 (red dots), CTA1
plus ER-mimicking lipids (blue dots) and CTA1 treated with both PBA and ER mimicking lipids
(yellow dots) was plotted as a function of temperature. The overlay data from far-UV CD
measurements are presented in J, from near-UV CD measurements in K, and fluorescence
spectroscopy in L.
39

Table 3-2 Summary of CTA1 Chain Experiments with PBA and ER Mimicking
Membranes

CTA1

Far UV Tm (°C )

Near UV Tm (°C )

Fluorescence Tm (°C )
±

range

of

independent expt.

+

34.8 ± 0.7

31.5 ± 0.5

34.4 ± 0.6

+ (POPC:POPG)

37.7 ± 1.0

33.6 ± 1.0

36.8 ± 0.8

42.5 ± 0.8

36.3 ± 1.0

39.7 ± 0.7

+

PBA

+

(POPC:POPG)
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2

3.5

Discussion

Ricin, like other A-B bacterial toxins, binds to a surface receptor and is endocytosed for
retrograde transport from the endosomes to the Golgi and then to the ER. Inside the ER, the
disulfide bond joining the A and B chains is reduced, allowing A subunit displacement from the
holotoxin and subsequent unfolding of the A chain. Previous work in our lab has shown that
CTA1 is very unstable and spontaneously unfolds at physiological temperatures. The isolated
CTA1 subunit has disturbed secondary and tertiary structures at 37°C, so it appears as an ERAD
substrate. In comparison, the isolated RTA subunit is stable at physiological temperature. This
work highlights that although CTA1 and ricin A chain use a similar ERAD-dependent
translocation pathway, they have their own distinct set of events. RTA and CTA1 both use
ERAD system to escape into the cytosol, but they use different mechanisms to unfold. Our
experiments show that PBA interacts with the ricin holotoxin and RTA and causes stabilization
of RTA secondary structure much like it does for CTA1, though the degree of stabilization is less
when compared to that of CTA1. Still, the overall Tm of RTA bound with PBA is higher than the
Tm of CTA1 bound with PBA. This means ricin A chain neither by itself nor in presence of PBA
unfold spontaneously at physiological temperature. Lord’s group had suggested that anionic
lipids could destabilize the structure of ricin A chain at 37°C, so we characterized the unfolding
profile of RTA secondary structure in presence of anionic lipids. Our results demonstrate that
anionic lipids destabilize RTA even in the presence of PBA. Experiments with RTA preincubated with PBA were done to mimic in vivo conditions where ricin holotoxin is treated with
PBA before A-B subunit dissociation in the ER. PBA binds to the A subunit of the holotoxin
after which it is endocytosed and reaches the ER. Inside the ER, the A chain bound with PBA
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dissociates from the rest of the toxin and, on interaction with anionic lipids, gets destabilized and
unfolds. Hence, translocation of RTA still occurs from the ER and causes intoxication even in
the presence of PBA.
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3.6

Future Directions

To date, people have been searching for ricin therapeutics which would inhibit the enzyme
activity by directly binding to the toxin’s active site. But, finding an inhibitor that would bind
strongly to the A chain, be highly soluble, and be less toxic to the cells is difficult to find. So, we
thought of looking at an alternative method where we wanted to prevent unfolding of RTA inside
the ER and thereby stymie its escape from the ER to the cytosol.
PBA showed great promise in the case of CT but was not successful in the case of ricin. This
tells us that we cannot generalize the utilization of chemical chaperones based on the success
against one toxin. We have to screen chemical chaperones against each A-B toxin which uses the
ERAD system to escape into the cytosol. RTA is destabilized in presence of anionic lipids
despite PBA binding to it; we need to find chemical chaperones which stabilize by an alternative
mechanism, such as glycerol which refolds by the formation of hydration shell. 10% glycerol has
low therapeutic value, so we need to screen other chemical chaperones which use the same
mechanism for chaperonic action and at the same time has high therapeutic value. Despite
decades of research, it has been very challenging to come up with even a single inhibitor which
meet would all three of the aforementioned criteria. Hence, we should also screen chemical
chaperones as a therapeutic alternative along with the inhibitors.
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4

4.1

CHOLERA TOXIN A1 SUBUNIT: LIPIDS AND MECHANISM OF
TOXIN STABILIZATION & FOLDING
Introduction

After binding to its GM1 receptor, CT is endocytosed and then reaches the ER through
retrograde transport. A-B subunit dissociation in ER triggers ERAD and expels the unfolded
CTA1 subunit from the ER into the cytosol [1, 2, 3]. After reaching the cytosol, many toxin
molecules undergo proteasomal degradation but most escape degradation due to the arginineover-lysine amino acid bias in CTA1. Lysine residues are crucial for ubiquitination [4]. Then, the
A1 subunit refolds in presence of host factors in the cytosol [79, 80, 82]. CTA1, being a
transferase enzyme, transfers the ADP-ribose group from NAD+ to the GTP-bound Gsα. ADPribosylated Gsα cannot hydrolyze its bound ATP and thus constitutively activates adenylate
cyclase [64-72,76,80]. As an effect, the concentration of cAMP rises in the cytosol which in turn
activates the downstream substrate protein kinase A (PKA). PKA phosphorylates the cystic
fibrosis transmembrane regulator (CFTR) chloride ion channel and opens up the channel,
causing a massive exodus of chloride ions into the intestinal lumen and a corresponding watery
diarrhea. Since CTA1 is very unstable at physiological temperature, it must use host factors to
refold into an active conformation in the cytosol [65]. Since the target of CTA1, Gsα, is
localized at the inner periphery of the plasma membrane of intestine, we have hypothesized that
the membrane lipids could be one of the factors that may help in toxin refolding and stabilization
in the cytosol.
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4.2

Cholera Toxin & The Plasma Membrane

To date, all studies related to the interaction of CT with lipids have focused on the rafts located
on the outer leaflet of plasma membrane. CT binds with its B subunit to the GM1 receptors
which are localized in the lipid rafts. The role of lipid rafts in cellular trafficking of CT is well
established, but the role of membrane lipids on the activity of cytosolic CTA1 has not been
studied. Our previous experiments with the ER membrane mimics showed that, unlike ricin A
chain which is destabilized in presence of ER mimics, CTA1 remains unaffected in their
presence. Post-translocation into the cytosol, CTA1 dodges proteasomal degradation and
localizes around its Gsα substrate at the plasma membrane.
In this section, we focused our studies on the role of the plasma membrane in the refolding and
stabilization of toxin structure. The hypothesis was derived from the fact that CTA1 localizes to
the inner leaflet of the plasma membrane where its target protein Gsα is localized. Maratha
Vaughan’s group had shown two decades ago that addition of lipids to ARF6 and CTA1
increased the ADP-ribosylation activity of CTA1. Since then, there has not been any follow up to
this studying regards to the role of lipids in CTA1 activity [65,69].
In our study we first wanted to simulate the conditions at the cytosolic face of the intestinal
plasma membrane. As no information about human intestinal lipid composition is available, we
chose the rat intestinal plasma membrane to model our membranes. Rats have been used as a
model animal to study cholera [ ]. So, we hypothesized that the behavior would be similar to that
of humans. We determined the acyl chain composition and the head groups according to the rat
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intestinal lipid profile [1- 5]. In order to model the inner leaflet we looked at various lipid
distributions and finally we chose the following composition as shown in Table 4-1 [6-9].
When we talk about the plasma membrane, it is difficult to ignore the presence of lipid rafts.
Rafts form unique domains of the plasma membrane which play a pivotal role in lipid – protein
organization [12,19]. CTA1, due to its proximity to the inner periphery of the plasma membrane,
can either interact with the general plasma membrane or it can interact with the specialized lipid
rafts. The chances of lipid raft interaction becomes high when we consider that the target protein
of CTA1, Gsα, is localized in the lipid rafts [17,18]. In order to simulate the inner lipid raft, we
mixed sphingomyelin and cholesterol with the two lipids unique to the inner leaflet (i.e.,
zwitterionic PE and anionic PS) [14]. The acyl chain selection was done from the intestinal lipid
composition. Sphingomyelin and cholesterol were mixed at 1:1 ratio [10-11, 13-15]. The final
composition of our lipid raft is shown in Table 4-2.
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Table 4-1 Lipid Composition of the Inner Leaflet of Rat Intestinal Plasma Membrane
Lipid

Percentage (%)

PLPE

27

SLPE

14

SAPE

5

SOPC

20

SAPC

14

PI (4,5) P2

1

PI (4) P

1

DOPI

1

PLPS

13

Palmitoyl Sphingomyelin

4
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Table 4-2 Composition of Model Lipid Rafts on the Inner Leaflet of Plasma Membrane
Lipid

Percentage (%)

Palmitoyl Sphingomyelin

30

Cholesterol

30

PLPE

25

PLPS

15
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4.3

Results:

CTA1 spontaneously unfolds at physiological temperatures inside the ER, yet it can refold in the
cytosol after evading the proteasomal degradation. It is evident that CTA1 takes the help of the
host factors to stabilize and refold into the correct conformation. In this chapter, we hypothesized
that the inner leaflet of plasma membrane lipids can stabilize and help in the process of refolding
of CTA1 subunit. We tested the role of both raft and non-raft plasma membrane domains on
toxin structure.
4.3.1

Binding of CTA1 Subunit with Lipid Rafts

The study of CT’s interaction with lipids to date has been indirect. It has remained confined to
the interaction of CTB with the GM1 receptors which are localized in lipid rafts. But, to date it is
unknown whether CTA1 can directly interact with lipids. As the A1 subunit refolds in the
cytosol and is involved in ADP ribosyl group transfer to Gsα localized on the inner leaflet of the
plasma membrane, we wanted to test whether it can interact with the lipid raft localized on the
inner leaflet of the plasma membrane. To test this theory, we did resonance energy transfer
(RET) experiments using pyrene –PE labeled head group. Figure 4-1(A-B) shows the spectra of
labeled and unlabeled lipid, respectively, and (Fig. 4-1 C) shows the calculated binding affinity
of CTA1. The change of color from blue to red signifies increase in lipid concentration. Figure 41A shows the pyrene signal at 380 nm. Each measurement of fluorescence intensity for both
labeled and unlabeled lipids are normalized based on CTA1 concentration at the start of the
experiment. The binding affinity curve is generated using equations explained in chapter 2. The
results show that, at 37°C, the dissociation constant of CTA1 to lipid rafts was calculated to be
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0.6 µM. Lipids containing pyrene-labeled head group were mixed with lipids containing
unlabeled head group. The excitation wavelength for pyrene is the emission of tryptophan
fluorescence. CTA1 on interacting with the membrane lipid rafts came in close proximity to the
pyrene labeled fluorophore at the head group of phospholipids and transferred its energy from
tryptophan emission to pyrene. Since this energy transfer can take place only when the two
fluorophores are in close proximity, it signifies interaction between the lipid rafts and CTA1.
4.3.2

Binding of CTA1 Subunit with the Inner Leaflet of the Non-Raft Plasma
Membrane

Since a major portion of the inner leaflet of the plasma membrane is non-rafts, the probability of
CTA1 interacting with this region is also very high. We did a similar RET experiment like the
lipid rafts mentioned in the previous section. We used the lipid composition as mentioned in
Table 4-1 for unlabeled lipids and substituted 1% labeled pyrene PE lipids with that of PLPE
lipids for the labeled vesicles. This experiment would provide insight regarding whether the
interaction of CTA1 with membranes is lipid-specific or based on the general biophysical
properties of the membrane.
Figure 4-2(A-B) shows the spectra of labeled and unlabeled lipid, respectively, and the
calculated binding affinity of CTA1 to non-raft lipids. Fig. 4-2 C the change of color from blue
to red signifies an increase in lipid concentration. As described in the previous figure, Figure 42A shows the pyrene signal at 380 nm. Each measurement of fluorescence intensity for both
labeled and unlabeled lipids are normalized based on CTA1 concentration at the start of the
experiment. The results show that at 37°C the dissociation constant of CTA1 to non-raft lipid
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membranes was calculated to be 2.3 µM. Thus,. the binding of CTA1 to non-raft membranes is
weaker in comparison to the lipid rafts. This also means if the non-raft and lipid raft membranes
are kept in proximity to CTA1 then CTA1 would have a higher propensity to interact with the
lipid rafts than the non-raft membranes.

4.3.3

Binding of CTA1-ΔA13 Subunit with the Lipid Rafts and the Non-Raft Plasma
Membrane

Previous experiments by the Teter lab have shown that the hydrophobic C-terminal domain of
CTA1 (i.e. the A13 subdomain) is not involved with toxin translocation to the cytosol .
However, we hypothesized that the toxin interaction with lipid rafts and the non-raft lipids is
involves the CTA1-A13 subdomain. We used a CTA1deletion construct lacking the A13
subdomain to test our hypothesis. It is to be noted that the CTA1 has 3 tryptophans whereas
CTA1-A13 deletion construct has just one of them [72]. Figure 4-3 (A-B) shows interaction of
CTA1- A13 with the labeled and unlabeled lipid rafts respectively. Figure 4-3 (D-E) shows
interaction of A13 with the labeled and unlabeled non- rafts respectively. Figure 4-3 (C&F)
shows the fitting to calculate the dissociation constant with the rafts and the non –raft lipid
membranes respectively. In both the cases we saw that there was hardly any interaction between
A13 deletion construct either with the lipid rafts or the non-rafts membranes. This suggests the Cterminal hydrophobic domain of CTA1 targets it o the plasma membrane and lipid rafts.
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B

C

Figure 4-1 Binding of CTA1 to Lipid Raft Membranes
Resonance energy transfer of CTA1 using 1% pyrene-PE labeled lipids added to the model lipid
rafts in borate buffer at pH 7.0 and 37°C. A) indicates tryptophan energy transfer in the presence
of labeled pyrene lipids. B) Fluorescence in presence of unlabeled lipids. C) shows the fitting to
calculate the dissociation constant; KD = 0.6 µM.
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B

C

Figure 4-2 Binding of CTA1 to Inner Leaflet of Plasma Membranes
Resonance energy transfer of CTA1 using 1% pyrene-PE labeled lipids added to the model inner
leaflet of the plasma membrane in borate buffer at pH 7.0 and 37°C. A) indicates tryptophan
resonance energy transfer in the presence of labeled pyrene lipids. B) Fluorescence in presence
of unlabeled lipids. C) shows the fitting to calculate the dissociation constant; KD= 2.3 µM
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Figure 4-3 Binding of the A1-3Deletion Construct with the Lipid rafts and the Non-Raft
Plasma Membrane
(A & D) Resonance energy transfer of the CTA1 deletion construct using 1% pyrene-PE labeled
lipids added to the model lipid rafts and non-rafts, respectively, in borate buffer at pH 7.0 and
37°C. (B & E) Fluorescence of the deletion construct in the presence of unlabeled lipid rafts and
non-raft lipids respectively. (C & F) show the fitting to calculate the dissociation constant in
presence of lipid rafts and non-raft lipids, respectively.
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4.3.4

Thermal Unfolding of CTA1 in the Presence of Lipid Rafts

CTA1 refolds in the cytosol after evading proteasomal degradation, and we hypothesized that
this refolding involves an interaction with lipid rafts. Using CD and fluorescence spectroscopy,
we wanted to observe possible changes to the structure of CTA1.. Our previous study with ERmimicking membrane lipids showed that these lipids destabilize RTA but not CTA1 (Chapter 3).
Lipid rafts have a more ordered structure than ER membrane lipids and could stabilize the
tertiary structure of CTA1. We conducted simultaneous recordings of far-UV CD, near-UV CD,
and fluorescence at each temperature to remove inconsistency in the results due to sample
variation. We recorded the near-UV spectra from 250-300 nm. Aromatic residues such as (Trp,
Tyr and Phe) and disulfide bonds give a signal in this region, although CTA1 does not have any
disulfide bonds. The aromatic amino acids tyrosine and tryptophan contribute an intramolecular
signal around 280 nm. Overall, there are 15 tyrosines and 3 tryptophans in CTA1.
The melting temperature (Tm) for CTA1 tertiary structure was calculated by plotting the mean
molar ellipticity [θ] at 280 nm as a function of temperature [Fig. 4-4]. The temperature was
raised from 20 to 60°C as denoted by the change of color from blue to red in the spectral data.
Fig. 4-4A, B and C show the tertiary structure spectra of CTA1 by itself , CTA1 in the presence
of non-raft lipids, and CTA1 in the presence of lipid rafts, respectively Fig. 4-4E, F and G show
the secondary structure spectra of CTA1 by itself, CTA1 in the presence of non-raft lipids and
CTA1 in the presence of lipid rafts, respectively. Fig. 4-4 I, J and K shows the fluorescence
spectra of CTA1 by itself, CTA1 in the presence of non-raft lipids, and CTA1 in the presence of
lipid rafts, respectively.
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The results show that the presence of both raft and non-raft membrane lipids stabilized the
secondary structure of CTA1, but the stabilization caused by lipid rafts was very large as the Tm
was shifted upwards by 13°C to 47°C (Table 4-3). Non-raft lipids too stabilized
CTA1seceondary structure and the Tm was at 39°C (Table 4-3). Similarly, lipid rafts also
stabilized the tertiary structure of CTA1,and the Tm was shifted from 31 to 45°C. In comparison,
non-raft lipids only increased the tertiary structure Tm of CTA1 by 6°C to 36°C (Table 4-3).
Fluorescence spectroscopy studies were done using tryptophan fluorescence by exciting at 290
nm. We plotted the wavelength at maximum fluorescence intensity (λmax) as a function of
temperature. As the toxin unfolds, the λmax shifts from 334 nm to 342 nm which we plotted as a
function of temperature. Fluorescence spectroscopy studies also coincided with the CD data and
showed a shift in Tm from 34°Cfor untreated toxin to 44°C in presence of lipid rafts and in
comparison non-raft lipids shifted the Tm by 3°C to 37°C (Table 4-3). The stabilization caused by
non-raft lipids was much weaker compared to that of lipid rafts which can partially be explained
as the binding of CTA1 to non-raft lipids was weaker than the lipid rafts as shown previously in
the RET experiments.
Although it is widely agreed that lipid rafts do exist in the inner leaflet of the plasma membrane
but there is controversy about the presence of sphingomyelin as one of the components of the
lipid rafts in the inner leaflet. It is argued that sphingomyelin is mostly concentrated in the outer
leaflet and not in the inner leaflet, but, on the other hand, the localization of sphingomyelinase
enzyme in the inner leaflet of the plasma membrane raises suggests that sphingomyelin is indeed
located in the inner leaflet. So, to test this controversy, we substituted 30% sphingomyelin with
20% cholesterol and 10% PLPC in the lipid raft composition mentioned in Table 4-2. Fig 4-5 A,
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B and C shows the far-UV, near-UV and the fluorescence spectra, respectively for CTA1treated
with this alternative lipid raft composition Fig. 4-5 D, E, and F shows the overlay of the thermal
unfolding profile for the temperature induced loss of CTA1 secondary and tertiary structure.
Like, lipid rafts it also stabilized the tertiary structure of CTA1, and the Tm was shifted to 39°C.
(Table 4-3). Similarly, secondary structure was also stabilized and the Tm was at 44°C (Table 43). We plotted the wavelength at maximum fluorescence intensity (λmax) as a function of
temperature and showed a shift in Tm to 40°C in presence of rafts lacking sphigomyelin (Table 43). Overall, the data shows that CTA1 is stabilized by rafts lacking sphingomyelin.
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Figure 4-4 CTA1 Unfolding In Presence of Lipid Raft and Non-Raft Lipids
The thermal unfolding of CTA1 only (A,E,I), CTA1 treated with non-raft lipids (B,F,J) and
CTA1 with lipid rafts (C,G,K). The temperature dependent change in CTA1 structure was
monitored by near-UV CD (A,B,C), far-UV CD (E,F,G), and fluorescence spectroscopy (I,J,K).
The temperature was increased stepwise from 20°C-60°C as indicated by the change in color
from blue to red. In panels (D,H,L) the unfolding of CTA1 (red dots), CTA1 plus non-raft lipids
(blue dots) and CTA1 treated with lipid rafts (yellow dots) was plotted as a function of
temperature. The overlay data from far-UV CD measurements are presented in D, from near-UV
CD measurements in H, and fluorescence spectroscopy in L.
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Figure 4-5 CTA1 Unfolding In Presence of Lipid Rafts Lacking Sphingomyelin
The thermal unfolding of CTA1 treated with raft lipids lacking sphingomyelin and rich in
cholesterol. The temperature dependent change in CTA1 structure was monitored by far-UV CD
(A), near-UV CD (C) and fluorescence spectroscopy (E).

The temperature was increased

stepwise from 20°C-60°C as indicated by the change in color from blue to red. In panels (B,D,F)
the unfolding of CTA1 (red dots), CTA1 plus rafts lacking sphingomyelin (green dots) and
CTA1 treated with lipid rafts (yellow dots) was plotted as a function of temperature. The overlay
data from far-UV CD measurements are presented in (B), from near-UV CD measurements in
(D) and fluorescence spectroscopy in (F).
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Table 4-3 Summary of CTA1Thermal Unfolding Profiles in Presence of Lipid Rafts and
Non-Raft Membranes

CTA1

Far UV Tm (°C )

Near UV Tm (°C )

Fluorescence Tm (°C )

+

34 ± 1

31 ± 1

34 ± 1

+ Non-Raft

39 ± 2

37 ± 1

37 ± 1

+ Lipid Rafts

47 ± 2

45 ± 2

44 ± 1

44

39

40

+

Lipids

Rafts

Lacking
Sphingomyelin
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4.3.5

Refolding of CTA1in the Presence of Lipid Rafts and Non-Raft Membranes

Both raft and non-raft lipids stabilized the structure of CTA1 when they were initially mixed
with the folded toxin conformation. This stabilizing effect kept CTA1in a folded conformation at
37°C. However, CTA1 is in unfolded conformation when it is ejected out of the ER into the
cytosol. From this unfolded state, CTA1 refolds to an active conformation at physiological
temperature. We hypothesized that CTA1 uses lipid rafts or non-raft lipid membrane as one of
the host factors to refold into a folded conformation. To test this hypothesis, we recorded the
near and far-UV CD spectra for CTA1 at 18°C (blue lines) and then raised the temperature to
37°C. We added non-raft lipids (Fig 4-6 A-B) and rafts (Fig 4-6 C-D) to the toxin solution and
took readings after 5 min (light blue lines). We again recorded the spectrum of CTA1 post 30
min incubation (red line). As a control we added buffer to CTA1 and recorded near and far-UV
spectra at similar time intervals denoted by the color of the spectra (Fig. 4-6 E-F). Our results
show that in the presence of lipid rafts, the gradual loss of CTA1 structure and loss of signal was
reversed to an increase in signal though it was red shifted by 4 nm from 220 to 224 nm. This
shift of nπ* signal to higher wavelength signifies the movement of amino acid residues into a
more hydrophobic environment. Though there was gain in secondary structure, but the recovery
was not complete. The addition of lipid rafts to disordered CTA1 also resulted in a substantial
gain of tertiary structure. The presence of lipid rafts gave a similar microenvironment around
CTA1 aromatic residues to that of the folded 18°C toxin conformation (Fig. 4-6 D). Non-raft
lipids prevented the further loss of CTA1 secondary and tertiary structure but did not induce the
gain of structure observed for lipid rafts. Additional measurements taken 60 min after addition of
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lipid rafts or non-raft membranes did not show any further alteration to the secondary or tertiary
structure of CTA1 (not shown).
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D
CTA1 + Non-raft

F
CTA1 + Lipid raft

CTA1 only

Figure 4-6 CTA1 Refolding in Presence of Lipid Raft and Non-Raft Lipids
Effect of lipid rafts and non raft membranes on the refolding of unfolded CTA1. Panels A, Cand
E shows the changes in far-UV spectra of CTA1 and panel B,D,F shows the changes in Near UV
spectra of CTA1. For all figures, blue color indicates spectra of CTA1 only at 18°C, light blue
color indicates 5 min after reaching 37°C and red color indicates 35 min after reaching 37°C. For
panels (A-D) light blue color indicates 5 min after the addition of lipids and red indicates 35 min
past after the addition of lipids. For (E-F) light blue color indicates 5 min after addition of buffer
37°C and red indicates 35 min past addition of buffer at 37°C .
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4.3.6

DEA-BAG CTA1 ADP-Ribosylation Assay:

Our CD data showed the presence of lipid rafts not only stabilized CTA1 but also induced of the
unfolded toxin to regain an ordered confirmation. In fact, incubation of partially unfolded
CTA1with lipid rafts for 30 min at 37°C helped in restore the of tertiary structure of CTA1 to
that of the 18°C toxin structure. We now wanted to know whether this gain in structure
amounted to restoration of CTA1 activity at 37°C. CTA1 by itself has little or no activity at
37°C.
In order to test CTA1 activity, we used Diethylamino (benzylidine-amino) guanidine (DEABAG) which is a synthetic substrate for ADP-ribosylation. DEA-BAG is excited at 360 nm and
has an emission wavelength at 460 nm. DEA-BAG can bind to BioRad-AG 50W-X4 cationic
resins but loses its capacity to bind this resin once it is ADP-ribosylated. Addition of resin
removes unmodified DEA-BAG, so, the DEA-BAG left in solution are modified byy ADPribosylation. The experiment was run in triplicates for each toxin concentration. Four separate
condition CTA1 were monitored at 25°C; CTA1 at 37°C; CTA1 treated with lipid rafts at 25°C
before incubating at 37°C and CTA1 incubated 37°C to unfold the toxin and then treated with
lipid rafts (Fig. 4-7). The results clearly show that CTA1 at 37°C has no activity whereas at 25°C
it has significant amount of activity. Although CTA1 also at 37°C exhibited 20% of the maximal
signal obtained in the way, we view this as a background signal because there was no dosedependent increase in the signal with higher toxin concentration. CTA1 treated with lipid rafts
prior incubating at 37°C had the highest activity signifying the role of lipid rafts in stabilizing the
active structure of CTA1. CTA1 incubated at 37°C followed by treatment with lipid rafts had
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higher activity than CTA1 by itself at 25°C, and this level of activity was nearly equivalent to the
result obtained by pre-treatment of CTA1 of CTA1 with lipid rafts at 25°C. This shows that the
lipid rafts can refold disordered CTA1 into an active conformation.
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Figure 4-7 Effect of Lipid Rafts on CTA1 Activity
A DEA-BAG assay was used to monitor to activity of CTA1 by itself at 25°C (yellow), CTA1 at
37°C ( red) color. CTA1 treated with lipid rafts at 25°C before heating to 37°C (green), and
CTA1 incubated for 30 min. at 37°C before treatment with lipid rafts (blue), The increasing
fluorescent units indicate higher ADP ribosylation activity. Error bars (Std. Dev.) are smaller
than the presented symbols. One of the two representative experiments is shown.
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4.4

Discussion

Vibrio cholerae reaches the human intestine through contaminated water and sometimes through
food where it adheres to the walls of the small intestine followed by an explosive growth of
bacterial cells. In the intestinal lumen it releases CT which binds to the GM1 receptor found in
abundance on the apical surface of the intestinal cells. After CT binds to the cell surface, it is
endocytosed and follows the retrograde pathway to reach the ER. Inside the ER, the disulfide
bond between the CTA1 and CTA2 is reduced. Protein disulfide isomerase interacts with the
CTA1 subunit and dislodges CTA1 from the rest of the toxin. CTA1 by itself is very unstable at
physiological temperatures and at the neutral pH in the ER. The isolated CTA1subunit therefore
unfolds spontaneously in the ER and consequently triggers the ER quality control mechanism
known as ERAD. Unfolded CTA1 is purged out of the ER through either Sec 61 and/or Derlin-1
translocons, but CTA1 avoids proteasomal degradation in the cytosol as it has more arginines
than lysines (the latter is needed for ubiquitination and targeting to the 26 S proteasome). Once
CTA1 escapes the degradation process, it refolds in the cytosol into an active conformation with
the help of host factors. An interaction with ADP-ribosylation factor 6 (ARF-6) allows CTA1 to
transfer an ADP-ribosyl group to Gsα, thereby locking it in an GTP-bound active conformational
state. Since Gsα is localized to the inner leaflet of plasma membrane lipid rafts, we studied the
potential role of lipids in stabilizing and refolding cytosolic CTA1. We tested the affinity of
CTA1 for raft and non-raft lipids and saw that CTA1 has a higher binding affinity for lipid rafts
in comparison to non-raft lipids. This tells us that, in the presence of both raft and non-raft lipids
(i.e., the plasma membrane), the toxin would have a higher propensity to associate with raft
lipids.
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The study of secondary and tertiary structures of CTA1 in presence of raft and non-raft lipids
showed that the toxin structure was stabilized in the presence of both types of lipids. Since CTA1
by itself is very unstable at physiological temperature, it needs to associate with host factors to
regain and remain in an active conformation state. Here, we show that CTA1 can remain
stabilized after interacting with either raft or non-raft plasma membrane mimics. This interaction
also enhances the ADP-ribosylation activity of CTA1. Lipid raft were more effective than nonraft lipids at preventing the thermal disordering of CTA1. Furthermore, exposure to lipid rafts
not only allowed disordered CTA1 to regain some of its original conformation but also its
activity. In the presence of lipid rafts, the secondary structure spectrum of disordered CTA1
showed a shift to higher wavelength in the nπ* signal. Near-UV CD measurements indicated that
the tertiary structure of disordered CTA1 was almost restored to its native conformation 30 min
after the addition of lipid rafts. Both raft and non-raft lipids stabilized the structure of CTA1, but
only lipid rafts promoted the gain of CA1 secondary and tertiary structure after temperatureinduced unfolding of the toxin.
Overall, the interaction of CTA1 with lipids is possible when it localizes near the inner leaflet of
the plasma membrane. Whether this interaction itself is enough to stabilize the toxin needs
further experiments mentioned in the next section. Many other outstanding questions remain, like
the sequence of events from the stage where CTA1 leaves ER to where it gets into an active
conformation. There is always a possibility that cytosolic chaperones may play a role in folding
of the toxin, and then the interaction with lipids helps keep the toxin in a stabilized state to which
ARF6 interaction makes CTA1 highly active. Nonetheless, we show here that plasma membrane
lipids, and lipid rafts in particular, play a role in cholera intoxication.
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4.5

Future Directions

After escaping proteasomal degradation, CTA1 refolds in the cytosol with the assistance of host
factors. We showed that CTA1 can interact with lipid rafts that stabilize and partially refold
CTA1. ARF6 is known to stabilize CTA1 and enhance its enzymatic activity in-vitro, so ARF-6
may also play an in-vivo role in the activation of cytosolic CTA1. We predict that CTA1 ADPribosylation enzymatic activity in the presence of lipid rafts and ARF-6 will be greater than that
observed for in the presence of either lipid rafts or ARF6 alone. To test CTA1 activity in
presence of ARF6 and lipid rafts, we would do similar DEA-BAG ADP-ribosylation enzymatic
assays as mentioned in this chapter. We can use CHO cells expressing the β-adrenergic G
coupled protein receptor (βAR) that is activated by isoprenetol. We will treat these cells with
isoprenetol in the presence and absence of lidocaine (which disrups lipid rafts) to determine
whether the GSα-induced production of cAMP requires intact lipid rafts. If lidocaine inhibits
cAMP production, this would indicate GSα (and therefore CTA1) must be present in a lpid raft
environment for activity.
If lidocaine does not inhibit cAMP production, it would mean that GSα does not require a lipid
raft environment for activity. We could then transfect the CHO cells with an mCTA1 expression
vector that directly express CTA1 in cytosol. We would next test the levels of cAMP in mCTA1transfected cells incubated with or without lidocaine. If there is a drop in cAMP levels when the
lipid raft disruptor is added, this would demonstrate in-vivo CTA1 activity requires the presence
of lipid rafts. It is to be noted that lidocaine experiments for cholera intoxication cannot be done
by directly by adding CT to the βAR-CHO cells as its GM1 receptor on the cell surface is also
localized to lipid rafts. Hence, disruption of lipid rafts using lidocaine would cause delocalization
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of GM1 receptors and prevent toxin uptake. In general, these experiments will establish in-vivo
the role of lipid rafts in cholera intoxication.
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5

INTERFACIAL ACTIVATION OF HUMAN PANCREATIC PLA2:
INSIGHT INTO THE CHANGES IN MEMBRANE LIPIDS AND
PROTEIN STRUCTURE
5.1

Secretory

enzyme

(hIBPLA2)

Introduction

hydrolyzes

phospholipids

to

free

fatty

acids

and

lysophospholipids. It has been shown that the lipid hydrolysis products are involved various
pathological processes and inflammation [20-22]. It belongs to a family of interfacial enzymes
hence, binding to the lipid membrane is the critical step for enzyme activation [23]. Entropic and
desolvation components as well as nonpolar forces and electrostatic forces have been shown to
be key factors in enzyme lipid interaction and activation [24-26]. hIBPLA2 shows dormant and
latent activation under unique conditions depends on numerous factors depending on membrane
phase transition, structural features, charge and membrane charge [25,27-34].
For PLA2 activity, binding to the lipid membrane is a prerequisite, but, that is not enough for
enzyme activation. Jain et al have shown that the porcine group IB PLA2 (pIBPLA2) did not bind
to the pure DMPC membranes at temperatures lower or higher than the lipid phase transition
temperature (Tm) [35]. Surprisingly, it bound to the membrane on addition of the reaction
products of PLA2. Experiments with POPC showed that the activity of the enzyme was higher at
all temperatures in comparison with DPPC. With DPPC membranes the highest activity was
observed at temperatures bordering gel to fluid phase transition temperatures [28]. It was inferred
that the fluid phase facilitated enzyme insertion into the membrane which caused higher activity.
Another group has shown that the pIBPLA2 efficiently hydrolyzed lipids at temperatures below
the Tm but not above it. Once they rapidly changed the temperature from below to temperatures
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above the Tm, the enzyme showed highest activity when compared to the activity at temperatures
near Tm [36]. It was concluded that the biding to the membrane at the gel phase is essential for
activation. PLA2 activation and lipid hydrolysis has been filled with complexity due to various
factors highlighting variable nature of the isoforms, experimental methods and conditions used.
Factors such as charge on the membrane, thermal phase transition of lipids, presence of lipid
hydrolysis products structural changes both on the membrane and protein have been implicated
for the interfacial activation [37-39].
Till date no consensus has been reached with regard to the initiation of PLA2 activation. Previous
studies have shown that partial membrane insertion was essential for enhanced membrane
binding and activity of the pIBPLA2 [40,41]. Studies with group IIA PLA2 have shown that the
low activity state of the enzyme is the one which has lesser membrane insertion and
consequently, higher activity corresponds with deeper insertion into the membrane [42]. Biltonen
and colleagues have formulated two binding modes of PLA2 [24,43]. They have proposed that
structural transition of membrane bound PLA2 to another form may involve deeper membrane
insertion which might be the key to the interfacial activation. Studies involving pIBPLA2 and
cobra venom PLA2 using neutron reflection and ellipsometry suggests that bilayer penetration
and interfacial activation can be linked together [34]. At the same time Jain et.al argue that the
mechanism for interfacial activation as opposed to membrane insertion is more likely to be
product mediated enhanced membrane binding of enzyme [27, 44]. They contest membrane
insertion would force distortion of lipids which might be energetically unfavorable.
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To, test the theory behind the interfacial activation, preliminary experiments using human group
IB PLA2 (hIBPLA2) and V3W mutant of human group IIA PLA2 showed significant membrane
penetration [45, 46]. But, in depth study of temperature dependence and its correlation with
membrane insertion and PLA2 activity has not been studied so far. In this dissertation, we studied
the PLA2 activity in presence of different membrane composition having variable Tm and
alongside we studied the temperature dependence of membrane insertion of PLA2. To, test
whether the interfacial activation corresponds to the structural changes in the enzyme, we would
use circular dichroism to study the secondary and tertiary conformational changes involving the
enzyme activity. Previous studies conducted on hIBPLA2 have shown that like other PLA2
isoforms, it has increased activity in presence of anionic lipids.
5.2

Lipid Phase Transition:

Earlier studies have shown that hIBPLA2 like other PLA2 isoforms show increased enzymatic
activity in presence of membranes containing anionic lipids. In order to elucidate the role of the
negatively charged lipids in PLA2 activity, experiments were done with pure phosphatidylcholine
(PC) vesicles and compared with that of PC vesicles containing 30 mol% phosphatidylglycerol
(PG) [47, 52]. Phospholipids with PC head group are the most abundant phospholipid on the
outer membrane of the cell. Phosphatidylglycerol (PG) is most common phospholipid in the
outer membrane of gram positive bacteria. It was chosen because the mixture of PC and PG with
identical acyl chains has almost similar gel to fluid phase transition temperatures. Melting
temperature (Tm) for various pairs of lipid composition used are as follows:
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Table 5-1 List of Phase Transition Temperatures of Phospholipids
Membrane Phospholipids

Tm (°C)

POPC

-2

POPG

-4

DMPG

24

DMPC

23.5

DPPC

41.5

DPPG

42

DSPC

55.5

DSPG

54.5
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5.3

Results

Secretory PLA2 are involved in phospholipid hydrolysis into lysophospholipid and free fatty acid
and involved various pathophysiological processes and inflammation. Group IB PLA2 is an
interfacial enzyme hence it needs to bind to membranes for activity. But, there are many
evidences in literature to conclude that binding of the membrane is necessary but not sufficient
for activation. Various other factors that are involved are membrane charge, phase transition,
membrane structural features and presence of reaction products [24-26, 40, 46, 47, 54].
Conflicting results with pIBPLA2 enzyme activity using indirect fluorescence measurements at
basic pH and small unilamellar vesicles (SUV) showed that pIBPLA2 could bind to POPC
membranes and showed higher activity for all temperatures compared to DPPC. It has been
proposed that for PLA2 binding, gel phase is necessary and the binding weakens above melting
temperature of lipid membranes.
Since, the Tm of the similar acyl chains are similar, it prevents the formation of more than one
domain on the surface and hence it is homogenous. Mixing of lipids with different melting
temperature leads to formation of two separate domains making the system more complex. In
order to simplify things and study the effects of lipid phase transition on enzyme activity, the
homogeneity in the acyl chain composition was maintained. DMPC and DMPG system was
chosen as our model membrane to study membrane insertion as it could be analyzed within the
physiological temperature range.
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5.3.1

Thermal Phase Transition of Lipid Membranes

The fluorescence spectroscopy of DMPC vesicles containing laurdan as a fluorophore was used
to study the temperature dependent changes of membrane fluidity. With the rise in temperature
from 4°C to 40°C, the 440nm non relaxed component starts to decrease and at the same time, the
solvent relaxed component at 475nm starts to increase. Values for generalized polarization (GP)
plotted as a function of temperature showed sigmoidal decrease with the midpoint at Tm i.e. 23°C
This phase transition was found to be completely reversible. Membranes composed of DMPG
behaved almost similar to the DMPC alone with identical Tm values but showed slightly higher
values for GP at lower temperatures. The thermal profile was also overall similar to the DMPC
vesicles. Tighter packing between the DMPG molecules could be explained by the stronger
hydrogen bonding at temperatures lower than the phase transition temperature. Fluorescence
spectra of 70 mol% DMPC and 30 mol% DMPG containing laurdan as fluorophore show
common features between the pure DMPC and pure DMPG vesicles. The thermal profile shows
sharp sigmoidal transition of GP with Tm at 23.5 °C during heating while it 24 °C while cooling.
To distinguish between the effect of temperature and lipid phase transition on enzyme activity,
we varied the acyl chain length and degree of saturation of the phospholipids to have a wider
range of phase transition temperatures. We conducted the experiment at wide range of
temperatures starting below the phase transition temperature and then going above it. To study
the PLA2 as mentioned in the methods section, we used bisPyPC lipids which have pyrene
fluorophore attached to both the acyl chains. During PLA2 activity, the acyl chain at sn2 position
is cleaved giving a rise to higher monomer signal and lower excimer signal.
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When the

temperature (T) is < phase transition temperature (Tm), then the intensity of excimer signal is
higher than that of monomer signal and this ratio of monomer to excimer signal decreases
sharply as it reaches the Tm. Apart from DMPC and its corresponding PG, the lipids that we used
were, POPC, DPPC and DSPC with and without corresponding PGs. This Pure PCs serve as
control for the surface charge effect as they are neutral, unlike the PGs which have a net negative
charge of -1. It is to be noted that the phase transition temperature for the lipid mix
DMPC/DMPG (7:3) is 4-6°C higher than the pure DMPC vesicles. Similarly, in case of
DPPC/DPPG it was found to be 40-44°C and in case for DSPC/DSPG it was found to be 5256°C. As for POPC/POPG, we were unable to detect any phase transition between 2-60°C as
predicted [56-58].
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Figure 5-1 Membrane Mobility To Detect Phase Transition of LUVs
Temperature dependent spectra of LUVs containing 1 mol % of laurdan fluorophore in (A)
DMPC (B) DMPG and (C) DMPC/DMPG (7:3). In all the cases the the temperature was raised
from 10 to 37°C and then back to 10°C. The heating and cooling cycles for all the three
membranes are shown in (D) and the GP (generalized polarization) is plotted as a function of
temperature.
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5.3.2

Lipid Phase Transition Studies Using DSPC and DSPC/DSPG Vesicles

To detect the effect of temperature on the activity of hIBPLA2 in presence of pure DSPC and
DSPC/DSPG (7:3) LUVs, the temperature was ramped from 8 to 60°C. After PLA2 was added to
the DSPC vesicles at given temperature, there was very little activity for 21 min. Similarly, with
DSPC/DSPG LUVs there was very low initial activity though the overall activity was very high
i.e. 2 fold to that of DSPC zwitterionic vesicles. The initial catalytic activity for both the cases
reached its maximum value between 30 to 40°C. On the other hand, there was onset of high
activity DSPC/DSPG LUVs at 54°C approx. 10 min post addition of PLA2. Fig shows that
representative fluorescent spectra of bisPyPC In DSPC/DSPG at 54°C. Sudden activation of
PLA2 after long lag time of 34min with DSPC/DSPG was detected near the phase transition
temperature i.e. around 55°C but that was not seen with pure DSPC LUVs. Although the lag
increases as the temperature is raised from 48 to 56°C, the activity too becomes higher at higher
temperatures. Lag burst effect which is defined as abrupt transition from low to high activity
state was not detected when the temperature was higher than 56°C even after 1 hour of
incubation. This effect cannot be attributed to inactivation of the enzyme as it showed high
activity with (Rt/R0-1) value reached from 0.5 to 4 when the temperature was ramped from 32 to
58°C. While at 32°C and 58°C, even after incubation upto 1 hr, there was no rise in activity at
both the temperatures. When the temperature was shifted from 32 to 58°C, there was immediate
rise in activity showing that the enzyme was very much active at higher temperatures and also
highlighting the role of phase transition effect on interfacial activation of PLA2.
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Figure 5-2 Dependence of hIBPLA2 Activity using DSPC and DSPC/DSPG (7:3) Vesicles
A) Time dependent analysis of lipid hydrolysis by measuring fluorescence spectra bisPyPC after
every 1.7 min. PLA2 was added after 0.5 min and recorded 36 spectra. Inset shows initial rate of
lipid hydrolysis as a function temperature for both type of vesicles. (B) Representative
fluorescent spectra of DSPC/DSPG bisPyPC at 54°C 10 min. post addition of PLA2. Increase in
monomer signal decrease in excimer signal (470 nm). Savitzky-Golay algorithm 11 points were
used to smooth all the spectra. (C) Lipid hydrolysis by PLA2 for DSPC/DSPG at 56°C after 34
min.
\
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Figure 5-3 Temperature Effect of hIBPLA2 activity in Presence of DSPC/DSPG (7:3)
Vesicles
Solid lines indicate before and after adding PLA2 at 32°C, dotted line shows spectral distortion
while temperature shifting from 32 to 58 °C and grey spectra denotes at 58°C. (B) shows open
and closed circles shows 58 to 32°C respectively. (C)

shows all the spectra of bisPyPC

containing vesicles at 58°C for 8 min and then monitored for 30 min. (D) PLA2 was added at
56°C after that, the temperature was shifted to 42°C to 58°C and then back to 58°C.

81

5.3.3

Lipid Phase Transition Studies Using DPPC and DPPC/DPPG Vesicles

Onset of PLA2 activity was recorded with DPPC LUVs which are zwitterionic at temperatures
close to the phase transition temperatures e.g. 38-41°C. But, there was significantly much higher
activity as we added DPPC/DPPG (7:3). At temperature around 34-36°C i.e. at temperatures
lower but close to phase transition, incubation for 3 to 4 min. leads to higher activity. Whereas,
at 40-44°C i.e. at phase transition/near phase transition temperature, the burst in activity was
recorded after 15 min of incubation. At temperatures farther away from phase transition
temperature (30 and 50°C), there was no activity for 45 min. When we plotted the initial PLA2
activity as a function of temperature, we see very low signal for zwitterionic DPPC LUVs
compared to a very sharp activity peak with anionic DPPC/DPPG lipids at or near phase
transition temperature. This is seen in the fig. where we raised the temperature from 8 to 41°C in
presence of DPPC/DPPG (7:3) and immediately strong enzyme activation can be seen which was
not seen with DPPC vesicles. Similarly, when the temperature was raised from 8°C to 50°C,
there was sharp rise in enzyme activity although neither at 8°C nor at 50°C there was not too
high activity. This shows that when the liposomes undergo phase transition at 42-44°Cis what
triggers higher activity. Unlike DSPC/DSPG, DPPC/DPPG membrane showed 20 fold higher
activity than pure DPPC membranes.
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Figure 5-4 Thermal Dependence of hIBPLA2 Activity in Presence of DPPC and
DPPC/DPPG (7:3) Vesicles
(A) and (B) illustrates lipid hydrolysis kinetic curves of fluorescent spectra denoted by changes
in color from blue to red from 8 to 50°C. (C) Temperature dependent initial rate of hydrolysis of
both type of membranes. (D) Temperature effect on DPPC and DPPC/DPPG after adding at 8°C
and then shifting to 41°C after 23 min.
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5.3.4

Lipid Phase Transition Studies Using DMPC and DMPC/DMPG vesicles

Adding hIBPLA2 to DMPC and DMPC/DMPG evoked similar kind of response that of DPPC
and DPPC/DDPG but there was difference at the quantitative levels. Even with this LUV
composition the pattern of the results were the same i.e. high initial activity was recorded near
the phase transition temperature i.e. between 22 to 28°C. Pure DMPC vesicles showed highest
initial activity rate at 23°C and DMPC/DMPG showed highest activity at 28°C. The thermal
dependence of DMPC/DMPG membranes on interfacial activation of PLA2 was seen when no
activation recorded below 16°C during first 21 min of incubation but the activity started
increasing once the temperature was raised from 16 to 28°C. This activity phase was preceded by
lag phase whose timing decreased with the rise in temperature. The result also showed lot of
similarity with the DSPC/DSPG membranes which too showed higher activity than pure DSPC
membranes by 2 o 3 folds. Also like DPPC and DSPC LUVs, DMPC LUVs had 5°C lower Tm
than DMPC/DMPC mix.
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Figure 5-5 Thermal Dependence of hIBPLA2 Activity in Presence of DMPC and
DMPC/DMPG (7:3) Vesicle
(A) & (B) show lipid hydrolysis kinetics curves of fluorescent spectra denoted by changes in
color from blue to red from 8 to 50°C while the curves show PLA2 activity at particular
temperatures. (C) shows the initial PLA2 activity as a function of temperature.
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Figure 5-6 Temperature Induced or Spontaneous Activation of hIBPLA2 in Presence of
DMPC or DMPC/DMPG
DMPC vesicles (blue) after addition of PLA2 and red line denotes last spectrum after addition of
PLA2. In the inset the PLA2 activity is depicted versus time. (B) shows induction of activity
through temperature shift with DMPC or DMPC/DMPG vesicles. Vesicles were incubated at 8 to
50°C. Circles and squares denote DMPC and DMPC/DMPG respectively. Blue color represents
before shift in temperature and red color represents after shift in temperature. Open blue squares
represents absence of PLA2 activation in presence of DMPC/DMPG vesicles at 50 °C for 40
min.
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5.3.5

Lipid Phase Transition Studies Using POPC and POPC/POPG Vesicles

Pancreatic PLA2 showed very low activity against POPC and POPC/POPG LUV vesicles for the
temperature range 2 to 60°C. With POPC/POPG mix, the enzyme activity increases again as that
of only POPC alone but the value was much lower as compared to all the other lipid membrane
containing saturated acyl chains used before. At none of the temperatures, incubation for 1 hour
and above did not evoke higher PLA2 activity. Compared to the DMPC/PG, DPPC/PG and
DSPC/PG system, the POPC/PG has Tm near freezing temperature due to the unsaturation in its
acyl chains; refer Table 5-1. Therefore, it was not possible to induce high PLA2 activity just by
shifting the temperature e.g. from 42 to 1°C, 20 to 2°C and from 28 to 1°C. Even temperature
shifts from low to high values closer to Tm were also not effective. In many experiments POPC:
POPG (1:1) sample was rapidly frozen below 0°C in presence of hIBPLA2 for 10 min. and
swiftly the temperature was raised to 42, 20 and 8°C. In all of these experiments, the yield of
lipid hydrolysis products were higher compared to the hydrolysis observed at those temperatures
individually. In other words the hydrolysis was much more due to the changing of the
temperature than the temperature itself. Though, the effect with POPC/POPG on changing the
temperature is similar compared to other lipid mixtures, but the effect remains very small
compared to them.
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Figure 5-7 Thermal Dependence of PLA2 activity in Presence of POPC and POPC/POPG
Vesicles
(A) Shows lipid hydrolysis kinetics in presence of different percentages of POPG at 20, 36 and
56°C. (B) Initial activity of thermal dependence of lipid hydrolysis at various ratios of POPC and
POPG mix. (C) Effect on change of temperature on hIBPLA2 from 42 to -3 °C and then back to
42°C in presence of POPC/POPG (1:1).
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5.3.6

DMPC/ DMPG Membrane Phase Transition Containing Brominated Lipids

Among multiple factors that trigger high PLA2 activity, membrane insertion is one of them.
Whether the triggering PLA2 activity corresponds to deeper membrane insertion of hIBPLA2; is
unknown. To test this hypothesis; we did quantitative analysis of membrane insertion of
hIBPLA2 as a function of temperature using DMPC/DMPG membranes. Earlier studies have
shown that the N-terminal helix of hIBPLA2 can insert into the membrane. As the only Trp3 of
hIBPLA2 is located on the N terminal helix, we studied its fluorescence quenching with the use
of brominated lipids (Br2PCs) as described in the methods section.
Prior starting the study of temperature dependence on membrane insertion, we determined
whether there is an effect on the lipid phase transition of the DMPC /DMPG membrane system
on adding 20 mol% of Br2PC. We first did a temperature dependence study using laurdan as
membrane fluorophore. Presence of 20 mol% Br2PC in DMPC/DMPG membrane did affect the
membrane phase transition and caused linearization of the GP of laurdan. Once we reduced to 10
mol% of Br2PCs, both the sigmoidal shape of laurdan GP as well as the Tm value was restored
and comparable to that of vesicles without Br2PCs. Though the thermal profile of laurdan GP of
vesicles with 10 mol% Br2PC was less co-operative in comparison to vesicles without Br2PCs,
the phase transition was still taking place and also the tryptophan fluorescence quenching by the
brominated lipids. Due to this reason we proceeded with our study of membrane insertion of
hIBPLA2. As we were using high PLA2 concentration, we next accessed the effect on lipid phase
transition due to PLA2. Large unilamellar vesicles (LUV) were made containing DMPC, DMPG,
6,7Br2PC and laurdan at molar ratios of 59:30:10:1 and the spectra were collected after ramping
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the temperature 4°C to 50°C after adding 6μM of hIBPLA2. Laurdan, as we know can be directly
excited at λexc= 360nm but below 300nm it cannot be excited at all. In our experiment, we
decided to excite laurdan through the resonance energy transfer (RET) from tryptophan
fluorescence instead of exciting it directly. Laurdan fluorescence spectra along with tryptophan
fluorescence spectra signifying tryptophan to laurdan energy transfer. The intensity of tryptophan
fluorescence is diminished due to the quenching both by laurdan and 6,7 Br2PC. Important
conclusion from this experiment is that the use of high concentration PLA2 along with
brominated lipids did not have strong effect on the phase transition of the vesicle membrane.
This also meant that we could reliably record the dependence of N-terminal insertion of PLA2 as
a function of temperature.

90

Figure 5-8 DMPC/ DMPG Membrane Phase Transition Containing Brominated Lipids
10% 6,7 Br2PCcontaining DMPC/DMPG treated with hIBPLA2. In (A) & (B) the excitation
wavelength was 290 and 360 nm respectively. Temperature was ramped from 4 to 50°C and the
values correspond to intensities at 440 nm. (C) Shows thermal dependence of GP at 290 and 360
nm.

Th dotted and solid line indicates phase transition in presence cooling and heating

respectively, in absence of phospholipase.

(D) Shows the effect in phase transition of

DMPC/DMPG membranes in presence of 10% brominated lipids at 6, 7 (Squares), 11, 12
(Circles) and 9, 10 (Triangles). Closed symbols and dotted line corresponds correspond to
cooling while open and solid lines indicate heating. Phase transition in absence of brominated
lipids is indicated by grey line.
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5.3.7

Membrane Insertion of hIBPLA2

In order to quantify the depth of membrane insertion, differential quenching of Trp fluorescence
by the brominated lipids as a function temperature was done at different temperatures.
Dependence of Trp fluorescence intensity on temperature at 325nm for hIBPLA2 in buffer and
also bound to vesicles with or without brominated lipids. Similarly, like 325nm, we had obtained
spectral plots for other fixed wavelength yet, we chose this wavelength based on prior studies
related to membrane bound proteins [60] and secondly the blue shift observed upon hIBPLA2
[61] bound to the membrane signifies that the wavelength (λ) 325nm best illustrates the
properties of membrane bound proteins than the wavelength at maximum intensity (λmax). The
data also shows that in all case we observed decrease in Trp emission intensity with the rise in
temperature and there is variability in quenching based on the positioning of the bromines in
Br2PCs.
Fluorescence intensity as a whole depends on multiple factors and is denoted by

φF = k F

/ {kF + kic + kis + kq [Q]}. φF signifies the number of excited fluorophores that emits fluorescence
at the rate constant kF. kic, kis and kq denote rate constants of internal conversion, intersystem
crossing and direct quenching by the quencher at concentration [Q] [61]. Our observation about
the decrease in fluorescence intensity with the rise in temperature can be explained based on
increasing internal conversion kic and collisional quenching by the water or oxygen molecules
dissolved in water. Since the Trp emission intensity of PLA2 is lower when brominated lipids are
present in the vesicles than when not present shows the differential quenching by Br2PCs. At
lower temperatures, the efficiency of quenching changes as the distance of the halides from the
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membrane center decreases i.e. 6,7-Br2PC is farthest from the membrane center whereas 11,12Br2PC being the nearest. The sequence of quenching efficiency lower temperatures were as
follows: 6,7-Br2PC > 9,10-Br2PC > 11,12-Br2PC, whereas, at higher temperatures it was 9,10Br2PC > 6,7-Br2PC > 11,12-Br2PC. The simple inference of these results are that at cold
temperatures when the membrane is more rigid gel like state, the insertion is difficult and hence
Trp3 vicinity to 6,7 Br2PC causes more quenching. With the rise in temperature, the fluidity of
the membrane increases and with that the insertion of the N terminal towards the hydrophobic
hydrocarbon region inside the membrane eases, hence we see more quenching taking place by
the bromines attached to the 9,10 and later 11,12 positions of the lipid acyl chain. The data for
the quenching efficiencies were calculated for each temperature and were plotted against the
distance of bromine from the membrane center [53]. Those plots were then fitted with the
distribution curve equation as mentioned before.
All 3 parameters (S, hm and σ ) which describe fluorescence quenching at particular temperatures
were inferred from the best fits between simulated curve and the experimental data. The bell
shaped curves with a particular combination follows Gaussian distribution in such away which
fits all the three data points Experimental data shows the temperature dependence of quenching
parameters while raising the temperature at T< Tm, S and σ decrease and then they experience
little change above Tm [62]. We observed a significant drop in efficiency of quenching at higher
temperatures which we explain that it could be due to later diffusion of PLA2 and Br2PCs. The
fact that the lateral diffusion takes place below and not above the Tm probably shows the sharp
decrease in microviscosity of the membranes with the rise in temperature. At low temperatures
(4°C), the depth of insertion of the Trp3from the membrane center was found to be 9.8 Å which
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changed to 8.9 Å with an increase in temperature to 40°C. Hence, the result reflects the subtle
change in depth of membrane insertion by ~1 Å with the increasing temperature from 4 to 40°C
signifying the phase transition from gel to the liquid crystalline state.

94

Figure 5-9 Determination of Membrane Depth of Insertion of hIBPLA2
(A) hIBPLA2 by itself (6µM) is shown (inverse triangle); DMPC/DMPG vesicles with
brominated lipids; 6,7 Br2PCs (circle); 9,10 Br2PCs (triangle); 11,12 Br2PCs (square); without
brominated lipids (rhombus) (B) Temperature dependence of quenching of tryptophan
fluorescence by Br2PCs as a function their location with respect to the membrane center. (C)
Description of the distance from membrane center (hm), area under the curve (S) and dispersion
(σ) as a function of temperature
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5.3.8

Changes in hIBPLA2 Structure During Activation

Previous experiments with temperature shifts showed that temperature change induces phase
transition of DPPC/DPPG (7:3) that causes activation of hIBPLA2. This activation was followed
by conformational change of secondary and tertiary structure using circular dichroism (CD).
When the temperature was raised from 4°C to 38°C, we recorded drastic change in α-helical
content. At 222 nm n-π* transition decreases by ~20% whereas, there was very little change π-π*
at 208 nm. So, we have recoded real-time change in secondary structure of PLA2 from an
inactive to an active state. Slight decrease in π-π* signal at 208 nm followed by big change in nπ* signal at 222 nm signifies lower α-helical content where lower 222 nm signal indicates α-

helical content and the ratio between [θ]222/[θ]208 indicates formation of rigid helices which are
consistent with the NMR data published.
Simultaneous recording of secondary as well as tertiary structures were done parallely using near
UV CD and fluorescence. Vesicles containing 2.5 mol% bis-pyrene-PC showed rises in the
monomer signal at 378 nm when the temperature was shifted from 4 to 38°C. At 4°C, a weak
negative signal was recorded at 280 nm which changed to strong positive once the temperature
was raised to 38°C. Signal at 250 nm was generated due to the π-π* transition of the aromatic
side chain of Tyr and the n-σ* transitions were from the disulfides. The signal at 280 nm were
produced by Try and Trp whereas Phe weak signal lower wavelengths. But, as it is known that
disulfide signal is produced only when the dihedral angle between Cβ-S-S-Cβ were distorted.
Here, our data depicts the conformational changes arising due to changes in the aromatic side
chains of Tyr and Trp followed by global perturbation in tertiary structure possibly due to
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deformation in disulfide binds in the enzyme. hIBPLA2 showed hardly any near UV features and
the tryptophan fluorescence was detected which reversibly decreased at higher temperatures
through solvent quenching effects in absence of the lipid vesicles. This signified that changes in
presence of lipid vesicles were due to the binding and activation of the phospholipase enzyme
and not due to its intrinsic properties.
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Figure 5-10 Secondary Structural Changes in hIBPLA2 During Activation
(A) Far UV CD spectra of hIBPLA2 during activation induced by shifting the temperature from 4
to 38°C. 50 spectra were collected at 4 °C and 110 spectra were collected at 38 °C. Only the first
and the fiftieth spectra of both the temperatures are shown here. (B) Molar ellipticities as a
function of time is plotted for the two α-helical minima at 208 and 222 nm.

98

Figure 5-11 Tertiary Structural Change During Activation of hIBPLA2
Near-UV CD (A) with and (C) without DPPC/DPPG/bisPyPC membrane vesicles (B) and (D)
show fluorescent spectra with and without lipid respectively. Λex = 290 nm for bith the cases.
Blue, red and green color (solid) were measured at 4°C, 38°C and then back to 4°C respectively.
Red and green dotted lines indicate intermediate spectra during the heating and cooling process
respectively. The bisPyPC at initial 4°C in (B) is due to Tro to pyrene resonance energy transfer.
The difference between the green and blue spectra at 378 nm indicated by lipid hydrolysis.
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5.4

Discussion

Effect of temperature and the phase transition of PLA2 were studied previously and with the use
of varying lipid compositions and experimental conditions, there were conflicting results.
Initiation of PLA2 activity post lag phase is thought to be due to accumulation of reaction
products to a critical concentration in the membrane. Apitz-Castro’s group [27] showed that at
17°C when the reaction products accumulates upto total of 5 mol% or 9 mol% in the outer layer
caused activation of pIBPLA2 in presence of DMPC vesicles. To eliminate the lag phase, 20
mol% of both reaction products needed to be added. While in case of DPPC vesicles at 38°C
addition of 7-8.3 mol% of reaction products were required to overcome the lag phase. In
presence of POPC vesicles, additions of 5 ± 3 mol% of reaction products at 25°C were needed to
overcome the lag phase. Henshaw’s group [33] has shown that the role of reaction products is
dependent upon multiple factors like pH, temperature and calcium ion concentration. They
showed that presence of lipid hydrolysis products is not enough to trigger PLA2 activation. In
this work, we showed that temperature dependent change in physical state of the membrane
plays a critical role in PLA2 activation. Therefore, with the use of DSPC/DSPG lipid vesicles we
saw onset of activity when 8% lipids were hydrolyzed at 48-54°C whereas, 15% when the
temperature was 56°C. This result is in agreement with Henshaw’s observation [33] with DPPC
vesicles where higher amount of lipid hydrolysis products were needed at temperatures higher
than the melting temperature of the lipid vesicles. It was interesting to see that 8% of hydrolyzed
lipids did not trigger PLA2 activation at lower temperatures but shifting the temperature to 58°C
resulted in higher activity. Also, our data shows that PLA2 activation is possible without
significant amount of reaction products.
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Menashe’s group [36] stated that higher activity on shifting of temperature from T<Tm to T ≥Tm
was associated with stronger membrane binding. Our conclusions contradicts their claims as we
saw activity when we shifted the temperature from T>Tm to Tm. This shows that thermal
perturbation causes PLA2 activation and not strong membrane binding provided the temperature
is near Tm.
PLA2 activity depends on phase transition of lipid at Tm and also on the intrinsic optimal
temperature of the enzyme Topt. Highest activity was recorded when the phase transition
temperature and optimal temperature are close to each other. Topt for PLA2 has been observed to
be between 30 and 40°C which are close to the Tm for DPPC and DPPG. With the rise in anionic
surface, PLA2 activity increases and it peaks around the phase transition temperature of
DPPC/DPPG (7:3) membranes. As the difference Tm and Topt increases, the activity of PLA2
decreases. Hence, we recorded lowest activity in presence of POPC/POPG as the difference
between the Tm and Topt was the highest.
We also looked at the long standing controversy regarding the N terminal insertion of PLA2 and
its relation with enzyme activity. Many groups have suggested that deeper insertion could result
in higher onset of enzyme activity, while at the same time many groups have speculated about
membrane insertion at all [28,34,40,42]. Previous work in our lab has shown that hIBPLA2 can
insert in fluid membranes (POPC/POPG) such that the Trp3 of the N terminal is 9 Å from the
hydrophobic center of the membrane [45,46]. In this work we questioned that how much change
in insertion takes place at the Tm of lipid membranes. Our experiments show that with the
increase in temperature at T<Tm, there was overall increase in quenching, S. At T≥Tm, we
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observed a small change in quenching. This observation can be explained by the phenomena of
static quenching. At higher temperatures, the lateral diffusion of PLA2 and Br2PCs in more fluid
membranes causes the fluorophore (tryptophan) to easily dissociate from quencher (brominated
lipids) [55]. The dispersion denoted by σ, which showed sharper distance distribution as the
temperature approached Tm. Distance of the Trp3 from the membrane center denoted by hm,
decreased very little by 1.1 Å when the temperature was raised from 4 to 40°C. This showed that
the PLA2 has an optimal binding mode over the membrane which does not change during
membrane insertion during phase transition. This is in agreement with previous findings where it
was reported for hIBPLA2 that its interaction depends on optimally satisfying Columbic,
hydrophobic interactions and hydrogen bonding [45]. Our present model indicates that Lys121
and Lys122 are involved in interacting with the phosphate group of the lipids through ionic
interactions and Arg6, Lys7, Lys10 and Lys116 interacting through hydrogen bonding with the
oxygen of the lipid carbonyl atoms. The hydrophobic R groups, Trp3, Phe19 and Leu20 are
embedded inside the hydrophobic environment provided by the lipid acyl chains [45]. With the
rise in temperature from T<Tm to Tm cause the lipids membranes to undergo phase transition i.e.
from a gel to a fluid state which would promote smoother insertion into membrane. But, this
insertion is opposed by the ionic interactions and the hydrogen bonding with the lipid polar
groups which is supported by our membrane insertion experiments.
CD experiments with DPPC/DDPG vesicles showed the changes in secondary and tertiary
structure of hIBPLA2 when the temperature was raised from an inactive 4°C to an active 38°C.
Our data showed real time changes in hIBPLA2 secondary and tertiary structure for the first time
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and showed that the enzyme activation is accompanied by a drastic change in secondary and
tertiary structure.
To conclude, previous studies speculated two binding modes of PLA2 over membrane and it
transits between these two states while undergoing activation. Our data at least proves that out of
the two binding modes, membrane insertion is not one of them [24,42, 43]. Further studies are
needed to be done for other group members of PLA2 family which may use completely different
mechanism to interact with membrane and initiate activation.
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5.5

Future Directions

As previous experiments show significant change in secondary and tertiary structure, it is now
important to study the angular orientation of hIBPLA2 with ATR-FTIR. This study will elucidate
more about the correct positioning of PLA2 for activation. We would study this using these four
different acyl chains of lipids with different phase transitions. This will tell us how fluidity of the
membrane affects the orientation of the protein over the membrane.
We would also test the basic principles that we established using another closely related isoform
such as Group IIA PLA2. This study will tell us whether we observe similar structural changes
during enzyme activity or it is unique to its own isoform. We will also study the difference
between the membrane binding state and the transition state as often there is a difference
between the two states.

104

6

GENERAL DISCUSSION

This study elucidates the various roles of lipid membranes and their role in modulating protein
structure and function. In vivo, the lipid organization can be regulated by pressure, temperature,
voltage, pH regulation and even temperature. Also, proteins localized on the membranes too
control the fluidity and curvature of the membranes. Here, we have highlighted the role of lipids
in toxin structure and function. This is the first time the catalytic subunit of cholera toxin has
been shown to interact with the membranes and we showed that lipid membranes can indeed
stabilize its structure which may be a key event in the mechanism cholera toxin activation in the
cytosol. We also show that the influence of biophysical properties of organelle membranes over
proteins could be so strong that it can overrule the chaperonic effects of chemical molecules
associated with it. We show here two contrasting effects against the toxins which have totally
opposite characteristics. RTA by itself is stable at physiological temperatures but becomes
unstable, whereas, CTA1 is unstable but becomes stable in presence of lipids. Common features
of both these toxins are that they have a B subunit which has a specialized role to bind to
membrane bound receptors and follow a similar cellular pathway to reach the ER. In both the
cases the B subunit stabilizes A subunit as in their absence CTA1 becomes thermally sensitive,
whereas, RTA lipid sensitive.
In comparison, secretory lipase hIBPLA2 which is a membrane binding enzyme shows a change
in conformation during activation as the enzyme alters from its binding conformation towards an
active conformation. This alteration could be attributed to the positioning of the active site for a
better accessibility of its lipid substrate.
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We see that proteins or their subunits which are not meant to associate with the membrane lipids
could undergo drastic structural changes on association such as ricin A chain and CTA1.
Whereas, those enzymes that are meant to associate with membrane lipids, their function can be
regulated by altering the lipid composition or their surrounding environment like in hIBPLA2.
Hence, this study addresses the role of lipids on the structure of non pore forming toxins. Future
studies on other members of the A-B toxin family will not only help to elucidate the role of lipids
in cytotoxicity but also find a clue to design algorithms to predict the changes that a toxin may
undergo on interaction with lipids based on the protein structure.
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